penn medicine
penn surgery
penn surgery home penn surgery clinical penn surgery education penn surgery research penn surgery administration

Mark P. Johnson, M.D.
Pediatric Surgery

 
  • Profile Home
  • Appointments
  • Education
  • Societies
  • Research
  • Publications
  • Awards

Administrative Office:
Children’s Hospital of Philadelphia
34th Street and Civic Center Boulevard
5th Floor, Wood Center
Philadelphia, PA 19104
Administrative Assistant: Beth Carr
Administrative Telephone: 215-590-2747
Administrative Fax: 215-590-2447

Clinical Office:
Children’s Hospital of Philadelphia
34th Street and Civic Center Boulevard
5th Floor, Wood Center
Philadelphia, PA 19104
Clinical Telephone: 215-590-2747
Clinical Fax:
215-590-2447

johnsonma@email.chop.edu

Link to Children's Hospital of Philadelphia

 

Dr. Johnson is the Director of Obstetrical Services at The Center for Fetal Diagnosis and Treatment (CFDT) at The Children’s Hospital of Philadelphia (CHOP) and the Medical Director of CHOP’s Special Delivery Unit. He holds the George Loeb Harrison Endowed Research Chair in Fetal Therapy. He also serves as professor in the Departments of Surgery, Obstetrics & Gynecology, and Pediatrics at the University of Pennsylvania School of Medicine.

A true innovator in the fields of Obstetrics and Fetal Medicine, Dr. Johnson helped develop fetoscopic surgical procedures for twin-twin transfusion syndrome and prenatal treatment of fetal lower urinary tract obstructions. He has made significant discoveries examining long term developmental outcomes in children who have undergone fetal spina bifida repair, including demonstrated improvement in motor function in the lower extremities and a decreased need for shunting.

A practiced geneticist, Dr. Johnson collaborates with Alan Flake, MD to advance techniques for prenatal gene and stem cell therapy.

An invaluable member of the CFDT team, Dr. Johnson specializes in fetal obstructive uropathy and prenatal diagnosis and therapy. He says he is continually inspired by the diverse patient population at the CFDT and the often challenging conditions they face. His goal is to create the best possible outcomes for every patient and patient family. “I am proud of the 13 years I have been at CHOP. The CFDT has really made big advances in the multidisciplinary imaging and evaluation of pregnancies complicated by anomalies,” he says. “We continue to develop and refine techniques to treat complicated twin pregnancies, congenital tumors, urinary tract obstructions and inherited genetic diseases and improve survival rates and long term outcomes through stem cell and gene therapy.”

Dr. Johnson graduated Magna Cum Laude from Concordia College with a BA in Biology and he earned his medical degree from University of Minnesota Medical School. He completed his Obstetrics and Gynecology residency at University of Michigan Medical School and his Medical Genetics fellowship at Wayne State University School of Medicine. Prior to his appointment at CHOP, Dr. Johnson served as the Associate Director in the Division of Reproductive Genetics at Wayne State University Medical School and Hutzel Hospital in Detroit. He is board certified in medical and clinical genetics and in obstetrics and gynecology.

 
Faculty Appointments
2010 – present Professor, Departments of Surgery
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
 
2010 – present Professor, Departments of Obstetrics & Gynecology
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
 
2010 – present Professor, Department of Pediatrics
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
 
1999 – 2010 Associate Professor, Departments of Surgery
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
 
1999 – 2010

Associate Professor, Department of Pediatrics
University of Pennsylvania School of
Medicine, Philadelphia, Pennsylvania

 
1999 – 2010 Associate Professor, Departments of Obstetrics & Gynecology
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
 
1996 - 1998 Associate Professor, Center for Molecular Medicine and Genetics
Wayne State University Medical School
Detroit, Michigan
 
1996 - 1998 Associate Professor, Department of Pathology
Wayne State University School of Medicine / Hutzel Hospital
Detroit, Michigan
 
1996 - 1998 Associate Professor, Department of Obstetrics and Gynecology (Tenured)
Wayne State University School of Medicine / Hutzel Hospital
Detroit, Michigan
 
1994 - 1996 Assistant Professor, Center for Molecular Medicine and Genetics
Wayne State University Medical School
Detroit, Michigan
 
1992 - 1996 Assistant Professor, Department of Pathology
Wayne State University School of Medicine / Hutzel Hospital
Detroit, Michigan
 
1990 - 1996 Assistant Professor, Department of Obstetrics and Gynecology
Wayne State University School of Medicine / Hutzel Hospital
Detroit, Michigan
 
1991 - 1994 Assistant Professor, Department of Molecular Biology and Genetics
Wayne State University Medical School
Detroit, Michigan
 
1991 - 1993 Visiting Assistant Professor, Department of Obstetrics and Gynecology
Medical College of Ohio
Toledo, Ohio
 
1988 - 1990 Clinical Instructor, Department of Molecular Biology & Genetics
Wayne State University Medical School / Hutzel Hospital
Detroit, Michigan
 
1988 - 1990 Clinical Instructor, Department of Obstetrics and Gynecology
Wayne State University Medical School / Hutzel Hospital
Detroit, Michigan
 
Hospital and Administrative Appointments
2008 - present Medical Director, Special Delivery Unit,
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
 
1998 - present Professor, Division of Clinical Genetics
The Children’s Hospital of Philadelphia
Philadelphia, Pennsylvania
 
1998 - present Professor, Division of Pediatrics
The Children’s Hospital of Philadelphia
Philadelphia, Pennsylvania
 
1998 - present Professor, Division of Pediatric General & Thoracic Surgery
The Children’s Hospital of Philadelphia
Philadelphia, Pennsylvania
 
1998 - present Director of Obstetrical Services, The Center for Fetal Diagnosis & Treatment
The Children’s Hospital of Philadelphia
Philadelphia, Pennsylvania
 
1992 - 1998 Associate Clinical Director
Graduate Program in Genetic Counseling Center for Molecular Medicine & Genetics
Wayne State University School of Medicine
Detroit, Michigan
 
J1992 - 1998 Assistant Medical Director, Diagnostic Cytogenetics Laboratory,
Department of Pathology, Wayne State University School of Medicine
Detroit, Michigan
 
1991 - 1998 Associate Director, Division of Reproductive Genetics,
Department of Obstetrics and Gynecology
Wayne State University Medical School / Hutzel Hospital
Detroit, Michigan
 
1976 - 1979 Clinical Cytogenetic Technologist, Division of Medical Genetics
Department of Laboratory Medicine and Pathology
University of Minnesota Medical Center
Minneapolis, Minnesota
 
Other Appointments
2007 - present Member, Medical Advisory Board
The Fetal Hope Foundation
Littleton, Colorado
 
1976 - 1979 Clinical Cytogenetic Technologist, Division of Medical Genetics
Department of Laboratory Medicine and Pathology
University of Minnesota Medical Center
Minneapolis, Minnesota
 
Education/Training
1980 - 1984 MD - University of Minnesota Medical School
Minneapolis, Minnesota
 
1976 - 1980 MS - University of Minnesota
(Medical Genetics/Pathology)
Minneapolis, Minnesota
 
1972 - 1976 BA - Concordia College (Biology/Chemistry)
Moorhead, Minnesota
 
Postgraduate Training and Fellowship Appointments
July 1989 Participant, Short Course in Medical and
Experimental Mammalian Genetics
The Jackson Laboratory and The Johns Hopkins University, Bar Harbor, Maine
 
1988 - 1990 Fellow in Medical Genetics
Departments of Obstetrics & Gynecology, and Molecular Biology & Genetics
Hutzel Hospital and the Center for Molecular Biology & Genetics, Wayne State University
Detroit, Michigan
 
1984 - 1988 Obstetrics & Gynecology Resident
Department of Obstetrics & Gynecology
University of Michigan Medical Center
Ann Arbor, Michigan
 
1979 - 1980 Graduate Research Fellow
Division of Medical Genetics
Department of Laboratory Medicine & Pathology
University of Minnesota Medical Center
Minneapolis, Minnesota
 
Memberships/Societies
2005 - present Member, American Gynecologic and Obstetrical Society
 
2002 - present Member, American Institute of Ultrasound in Medicine
 
1998 - present Member, Alpha Omega Alpha Medical Honor Society, Beta Chapter, Detroit, Michigan
 
1997 President, International Fetal Medicine and Surgery Society
 
1996 - 2000 Member, Association of Professors of Human or Medical Genetics
 
1994 - present Member, The Central Association of Obstetricians and Gynecologists
 
1992 - 2000 Member, American Association for the Advancement of Science
 
1991 - 2000 Member, Sigma Xi, Scientific Research Society
 
1988 - 1998 Member, Michigan State Medical Society
 
1988 - 1998 Member, Wayne County Medical Society
 
1993 - present Member, Society of Maternal-Fetal Medicine
 
1988 - present Member, International Fetal Medicine and Surgery Society
 
1992 - present Founding Fellow, American College of Medical Genetics
 
1988 - present Member, American Society of Human Genetics
 
1992 - present Fellow, American College of Obstetrics and Gynecology
 
1986 - 1992 Junior Fellow, American College of Obstetrics and Gynecology
 
1984 - present Member, American Medical Association
 
Research
2001 - present Endowed Chair in Fetal Diagnosis & Treatment
 
2002 - 2010 Multicenter Trial of Fetal Myelomeningocele Repair
 
2001 - 2006 Twin-Twin Transfusion Trial
 
1997 Fetal Cells in Maternal Blood
 
1996 - 2001 Hematopoietic Stem Cell Transplantation in Utero
 
1994 - 1997 Prenatal Diagnosis Using Fetal Cells from Maternal Blood: Clinical Trial
   
 
Publications
Research Publications, Peer Reviewed
  1. Camargo M, Johnson MP, Cervenka J. Delineation of 13q- deletion by replication banding in retinoblastoma. Cytogenetics Cell Genetics 31(2):77, 1981.
  2. Johnson MP, Ramsey N, Cervenka J, Wang N. Retinoblastoma and its association with a deletion in chromosome #13: A survey using high resolution chromosome techniques. Cancer Genetics and Cytogenetics 6(1):29-37, May 1982.
  3. Johnson MP, Filipovich AH. Cytogenetic studies in Wiscott-Aldrich Syndrome: Identification of a case with a 6p chromosome abnormality. American Journal of Medical Genetics 23(3):765-773, Mar. 1986.
  4. Drugan A, Subramanian MG, Johnson MP, Evans MI. Amniotic fluid cortisol and a-fetoprotein in normal and aneuploid pregnancies. Fetal Diagnosis &Therapy 3(4):192-197, 1988.
  5. Drugan A, Dvorin E, Johnson MP, Uhlmann WR, Evans MI. The inadequacy of the current correction for maternal weight in maternal serum alpha-fetoprotein interpretation. Obstetrics & Gynecology 74(5):698-701, Nov. 1989.
  6. Wright DJ, Brindley BA, Koppitch FC, Drugan A, Johnson MP, Evans MI. Interpretation of chorionic illus sampling laboratory results is just as reliable as amniocentesis. Obstetrics & Gynecology 74(5):739-774, Nov. 1989.
  7. Johnson MP, Azuma T, Boudi FH, Taggart RT. RFLP for human cathepsin E (CTSE). Nucleic Acids Research 17(23):10147, Dec. 11, 1989.
  8. Johnson MP, Barr Jr. M, Qureshi F, Drugan A, Evans MI: Symmetrical intrauterine growth retardation is not symmetrical: organ specific gravimetric deficits in midtrimester and neonatal trisomy 18. Fetal Diagnosis & Therapy 4:110-119, 1989.
  9. Drugan A, Johnson MP, Dvorin E, Moody J, Krivchenia EL, Schwartz D, Evans MI. Aneuploidy with neural tube defects: Another reason for complete evaluation in patients with suspected ultrasound anomalies or elevated maternal serum alpha-fetoprotein. Fetal Diagnosis & Therapy 4(2-3):88-92, 1989.
  10. Sorokin Y, Johnson MP, Drugan A, Koppitch III FC, Evans MI. Amniotic fluid alpha-fetoprotein levels in the differential diagnosis of cystic hygroma. Fetal Diagnosis and Therapy 4(4):178-184, 1989.
  11. Drugan A, Bottoms SF, Johnson MP, Evans MI. Seasonal variation in conception does not appear to influence the rate of prenatal diagnosis of nondisjunction. Fetal Therapy 4(4):195-199, 1989.
  12. Drugan A, Koppitch FC, Williams JC, Johnson MP, Moghissi KS, Evans MI. Prenatal diagnosis following recurrent early pregnancy loss. Obstetrics & Gynecology 75(3 Pt 1):381-384, Mar. 1990.
  13. Johnson MP, Compton A, Drugan A, Evans MI. Metabolic control of von Gierke disease (glycogen storage disease type Ia) in pregnancy: Maintenance of euglycemia with cornstarch. Obstetrics & Gynecology 75(3 Pt 2):507-510, Mar. 1990.
  14. Schell DL, Drugan A, Brindley BA, Zador IE, Johnson MP, Schwartz DB, Evans MI. Combined ultrasonography and amniocentesis for pregnant women with elevated serum alpha-fetoprotein: Revising the risk estimate. Journal of Reproductive Medicine 35(5):543-546, May 1990.
  15. Johnson MP, Greb A, Goyert G, Drugan A, Qureshi F, Sacks A, Evans MI. Midtrimester diagnosis and dysmorphology in the 22q+ syndrome: Correlation of aneuploidy with low maternal serum alpha-fetoprotein and oligohydramnios. American Journal of Medical Genetics 36(1):94-96, May 1990.
  16. Evans MI, May M, Drugan A, Fletcher JC, Johnson MP, Sokol RJ. Selective termination: Clinical experience and residual risks. American Journal of Obstetrics & Gynecology 162(6):1568-1575, June 1990.
  17. Drugan A, Greb A, Johnson MP, Krivchenia EL, Uhlmann WR, Moghissi KS, Evans MI. Determinants of parental decision to abort or continue a pregnancy following prenatal diagnosis of chromosome anomalies. Prenatal Diagnosis 10(8):483-490, Aug. 1990.
  18. Treadwell MC, Thompson KE, Bottoms SF, Johnson MP, Evans MI. Perinatal characteristics and karyotypic assessment of the prenatally unsuspected phenotypically abnormal newborn. Obstetrics & Gynecology 76(3 Pt 1):378-380, Sept. 1990.
  19. Johnson MP, Drugan A, Koppitch FC, Uhlmann WR, Evans MI. Postmortem CVS: A better method for cytogenetic evaluation of fetal loss than culture of abortus material. American Journal of Obstetrics & Gynecology 163(5 Pt 1):1505-1510, Nov. 1990.
  20. Evans MI, Johnson MP, Holzgreve W. Maternal-fetal conflict: Fetal therapy, the next generation. Women's Health Issues 1(1):31-33, 1990.
  21. Isada NB, Koppitch FC III, Johnson MP, Evans MI. Does the color of amniotic fluid still matter? Fetal Diagnosis & Therapy 5(3-4):165-167, 1990.
  22. Evans MI, Sacks AL, Johnson MP, Robichaux III AG, May M, Moghissi KS. Sequential invasive assessment of fetal renal function, and the in utero treatment of fetal obstructive uropathies. Obstetrics & Gynecology 77(4):545-550, Apr. 1991.
  23. Evans MI, Johnson MP, Koppitch FC, Thompson KE, Sokol RJ, Drugan A. Transabdominal chorionic villus sampling for rapid karyotyping in advanced gestation. Journal of Reproductive Medicine 36(6):416-418, June 1991.
  24. Sorokin Y, Johnson MP, Uhlmann WR, Zador IE, Drugan A, Koppitch III FC, Moody J, Evans MI. Postmortem chorionic villus sampling: Correlation of cytogenetic and ultrasound findings. American Journal of Medical Genetics 39(3):314-316, June 1, 1991.
  25. Evans MI, Greb A, Kunkel LM, Sacks AJ, Johnson MP, Boehm C, Kazazian HH, Hoffman EP. In utero fetal muscle biopsy for the diagnosis of Duchenne Muscular Dystrophy. American Journal of Obstetrics & Gynecology 165(3):728-732, Sept. 1991.
  26. Haefner H, Andersen HF, Johnson MP. Vaginal laceration following a jet ski accident. Obstetrics & Gynecology 78(5 Pt 2):986-988, Nov. 1991.
  27. Isada NB, Parr DP, Johnson MP, Straus SE, Holzgreve W, Qureshi F, Evans MI. In utero diagnosis of congenital varicella-zoster virus (VZV) infection by chorionic villus sampling (CVS) using polymerase chain reaction (PCR). American Journal of Obstetrics & Gynecology 165(6 Pt 1):1727-1730, Dec. 1991.
  28. Evans MI, Johnson MP. Prenatal diagnosis in the '90s. A symposium. Journal of Reproductive Medicine 37(5):387-8, May 1992.
  29. Evans MI, Johnson MP, Holzgreve W. Chorionic villus sampling. Journal of Reproductive Medicine 37(5):389-94, May 1992.
  30. Pryde PG, Odgers AE, Isada NB, Johnson MP, Evans MI. Determinants for parental decision to abort (DTA) or continue for non-aneuploid ultrasound detected abnormalities. Obstetrics & Gynecology 80(1):52-56, July 1992.
  31. Isada NB, Pryde PG, Johnson MP, Hallak M, Blessed WB, Evans MI. Fetal intracardiac potassium chloride injection to avoid the hopeless resuscitation of an abnormal abortus: I. Clinical issues. Obstetrics & Gynecology 80(2):296-299, Aug. 1992.
  32. Fletcher JC, Isada NB, Pryde PG, Johnson MP, Evans MI. Fetal intracardiac potassium chloride infection to avoid the hopeless resuscitation of an abnormal abortus: II. Ethical issues. Obstetrics & Gynecology 80(2):310-313, Aug. 1992.
  33. Hallak M, Johnson MP, Pryde PG, Isada NB, Zador IE, Evans MI. Chorionic villus sampling: transabdominal versus transcervical approach in more than 4000 cases. Obstetrics & Gynecology 80(3 Pt 1):349-352, Sept. 1992.
  34. Isada NB, Sorokin Y, Drugan A, Johnson MP, Zador IE, Evans MI. First trimester inter-fetal size variation in well-dated multifetal pregnancies (MFP). Fetal Diagnosis and Therapy 7(2):82-86, 1992.
  35. Ginsburg KA, Johnson MP, Sacco AG, Rousseau MF, Blacker CM, Moghissi KS. Tetraploidy associated with human pronuclear embryo cryopreservation: A case report. Journal of Assisted Reproduction & Genetics 9(5):484-488, Oct. 1992.
  36. Pryde PG, Isada NB, Johnson MP, Grundy H, Evans MI. Triply discordant triplets: Probability, management options, and risks. American Journal of Medical Genetics 44(3):361-364, Oct. 1, 1992.
  37. Evans MI, Klinger KW, Isada NB, Shook D, Holzgreve W, McGuire N, Johnson MP. Rapid prenatal diagnosis by fluorescent in situ hybridization of chorionic villi: An adjunct to long term culture and karyotype. American Journal of Obstetrics & Gynecology 167(6):1522-1525, Dec. 1992.
  38. Drugan A, Johnson MP, Isada NB, Holzgreve W, Zador IE, Dombrowski MP, Sokol RJ, Hallak M, Evans MI. The smaller than expected first trimester fetus is at increased risk for chromosome anomalies. American Journal of Obstetrics & Gynecology 167(6):1525-1528, Dec. 1992.
  39. Pryde PG, Isada NB, Johnson MP, Evans MI: Familial omphalocele (FO): considerations in genetic counseling. American Journal of Medical Genetics 44: 624-627, 1992.
  40. Johnson MP, Johnson A, Holzgreve W, Isada NB, Wapner R, Treadwell MC, Heeger S, Evans MI. First trimester simple hygroma: Cause and outcome. American Journal of Obstetrics & Gynecology 168(1 Pt 1):156-161, Jan. 1993.
  41. Kalousek DK, Langlois S, Barrett I, Yam I, Wilson RD, Howard-Peebles PN, Johnson MP, Giorgiutti E. Uniparental disomy for chromosome 16 in humans. American Journal of Human Genetics 52(1):8-16, Jan. 1993.
  42. Qureshi F, Jacques SM, Evans MI, Johnson MP, Yang SS. Skeletal histopathology in fetuses with chondroectodermal dysplasia (Ellis-Van Ceveld Syndrome). American Journal of Medical Genetics 45(4):471-476, Feb. 15, 1993.
  43. Drugan A, O'Brien JE, Gambino R, Johnson MP, Evans MI. Similarity of twins to singleton maternal serum alpha-fetoprotein ratio by race: no need to establish specific multifetal tables. Fetal Diagnosis & Therapy 8(2):84-89, Mar./Apr. 1993.
  44. Johnson MP, Childs MD, Isada NB, Koppitch III GC, Evans MI. Viable pregnancies after diagnosis of trisomy 16 by CVS: Lethal aneuploidy compartmentalized to the trophoblast. Fetal Diagnosis & Therapy 8(2):102-109, Mar./Apr. 1993.
  45. Evans MI, Pryde PG, Evans WJ, Johnson MP. The choices women make about prenatal diagnosis. Fetal Diagnosis and Therapy 8(Suppl 1):70-80, Apr. 1993.
  46. Evans MI, Farrell SA, Greb A, Ray P, Johnson MP, Hoffman E. In utero fetal muscle biopsy for the diagnosis of Duchenne muscular dystrophy in a female fetus “suddenly at risk”. American Journal of Medical Genetics 46(3):309-312, May 15, 1993.
  47. Saleh AA, Ozawa T, Dombrowski MP, Isada NB, Johnson MP, Evans MI, Bottoms SF, Mammen EF. Amniotic fluid platelet factor and beta-thromboglobulin. Fetal Diagnosis & Therapy 8(3):165-167, May/June 1993.
  48. Saleh AA, Isada NB, Johnson MP, Sokol RJ, Dombrowski MP, Evans MI. Amniotic fluid acetylcholinesterase is found in gastroschisis but not omphalocele. Fetal Diagnosis & Therapy 8(3):168-170, May/June 1993.
  49. Saleh AA, Ozawa T, Isada NB, Johnson MP, Dombrowski MP, Evans MI, Treadwell MB, Mammen EF. Amniotic fluid platelet factor 4 and beta-thromboglobulin as markers of structural abnormalities. Fetal Diagnosis & Therapy 8(3):175-177, May/June 1993.
  50. Drugan A, Johnson MP, Isada NB, Evans MI. Age of gestation (size) at embryonic demise: Tailoring counseling for lethal versus potentially viable aneuploidy. Fetal Diagnosis & Therapy 8(3):178-181, May/June 1993.
  51. Blessed WB, Coughlin J, Johnson MP, Evans MI, Jewell MR, Goyert GL, Schwartz DB, Klein MD. Immediate delivery room repair of fetal abdominal wall defects. Fetal Diagnosis & Therapy 8(3):203-208, May/June1993.
  52. Pryde PG, Qureshi F, Hallak M, Kupsky W, Johnson MP, Evans MI. Two consecutive hydrolethalis syndrome-affected pregnancies in a nonconsanguinous black couple: Discussion of problems in prenatal differential diagnosis of midline malformation syndromes. American Journal of Medical Genetics 46(5):537-541, June 15, 1993.
  53. Evans MI, Dommergues M, Wapner RJ, Lynch L, Dumez Y, Goldberg JD, Zador IE, Nicolaides KH, Johnson MP, Golbus MS, Boulot P, Berkowitz RL. Efficacy of transabdominal multifetal pregnancy reduction: Collaborative experience among the world's largest centers. Obstetrics & Gynecology 82(1):61-67, July 1993.
  54. Pryde PG, Drugan A, Johnson MP, Isada NB, Evans MI. Prenatal diagnosis: Choices women make about pursuing testing and acting on abnormal results. Clinical Obstetrics & Gynecology 36(3):469-509, Sept. 1993.
  55. Johnson MP, Barr M Jr, Treadwell MC, Michaelson J, Isada NB, Pryde PG, Dombrowski MP, Cotton DB, Evans MI. Fetal leg and femur: Foot length ratio: A marker for trisomy 21. American Journal of Obstetrics & Gynecology 169(3):557-563, Sept. 1993.
  56. Evans IE, Johnson MP, Isada NB. The genetics revolution and the role of the obstetrician. Clinical Obstetrics & Gynecology 36(3):463-465, Sept. 1993.
  57. Evans MI, Gleicher E, Feingold E, Johnson MP, Sokol RJ. The fiscal impact of the Medicaid abortion funding ban in Michigan. Obstetrics & Gynecology 82(4 Pt 1):555-560, Oct. 1993.
  58. Jelsema RD, Isada NB, Harrison MR, Johnson MP, Kazzi N, Evans MI. Prenatal diagnosis of Brachmann-de Lange syndrome: Congenital diaphragmatic hernia not amenable to prenatal repair. American Journal of Medical Genetics 47(7):1022-1023, Nov. 15, 1993.
  59. O'Brien JE, Drugan A, Chervenak FA, Johnson MP, Isada NB, Hallak M, Evans MI. Maternal serum alpha-fetoprotein screening: The need to use race specific medians in Asians. Fetal Diagnosis & Therapy 8(6):367-370, Nov./Dec. 1993.
  60. Isada NB, Qureshi F, Tout MJ, Sonaglia CS, Johnson MP, Evans MI. Meroanencephaly with pulmonary glial nodules and adrenal medullary hyperplasia. Fetal Diagnosis & Therapy 8(6):424-429, Nov./Dec. 1993.
  61. Evans MI, Johnson MP, Holzgreve W. Early amniocentesis: What exactly does that mean? Journal of Reproductive Medicine 39(2):77-78, Feb. 1994.
  62. Evans MI, Dommergues M, Timor-Tritsch I, Zador I, Wapner RJ, Lynch L, Dumez Y, Goldberg JD, Nicolaides KH, Johnson MP, Golbus MS, Boulot P, Aknin AJ, Monteagudo A, Berkowitz RL. Trans-abdominal vs. transcervical/vaginal multifetal pregnancy reduction: International collaborative experi-ence of more than 1000 cases. American Journal of Obstetrics & Gynecology 170(3):902-909, Mar. 1994.
  63. Johnson MP, Michaelson J, Barr M Jr, Treadwell MC, Isada NB, Dombrowski MP, Pryde PG, Addis J, Evans MI. Sonographic screening for trisomy 21: Fetal humerus: Foot length ratio, a useful new marker. Fetal Diagnosis & Therapy 9(2): 130-38, Mar./Apr. 1994.
  64. Saleh AA, Pryde PG, Isada NB, Johnson MP, Evans MI, Johnston JM. Platelet activating factor - acytylhydrolase (PAF-AH) activity following chorionic villus sampling and amniocentesis. Journal of the Society for Gynecologic Investigation 1(2):135-137, Apr.-June 1994.
  65. Sorokin Y, Johnson MP, Rogowski N, Richardson DA, Evans MI. Obstetrical and gynecologic dys-function in the Ehlers-Danlos syndrome. Journal of Reproductive Medicine 39(4):281-284, Apr. 1994.
  66. Dombrowski MP, Berry SM, Johnson MP, Saleh AA, Sokol RJ: Birth weight/length ratio, ponderal index, placental weight, and birth weight/placental ratios in a large population. Archives of Pediatric Adolescent Medicine 148(5):508-512, May 1994.
  67. Johnson MP, Bukowski TP, Reitleman C, Isada NB, Pryde PG, Evans MI. In utero surgical treatment of fetal obstructive uropathy: A new comprehensive approach to identify appropriate candidates for vesicoamniotic shunt therapy. American Journal of Obstetrics & Gynecology 170(6):1770-1779, June 1994.
  68. Evans MI, Goldberg JD, Dommergues M, Wapner RJ, Lynch L, Dock BS, Horenstein J, Golbus MS, Rodeck CH, Dumez Y, Holzgreve W, Timor-Tritsch I, Johnson MP, Isada NB, Berkowitz RL. Efficacy of second trimester selective termination for fetal abnormalities: international collaborative experience among the world's largest centers. American Journal of Obstetrics & Gynecology 171(1):90-94, July 1994.
  69. Reichler A, Hume Jr. RF, Drugan A, Bardicef M, Isada NB, Johnson MP, Evans MI. Risk of anomalies as a function of level of elevated maternal serum alpha-fetoprotein. American Journal of Obstetrics & Gynecology 171(4):1052-1055, Oct. 1994.
  70. Evans ML, Holzgreve W, Johnson MP, Ganshirt D, Sokol RJ. Fetal cell testing: Societal and ethical speculations. Annals of the New York Academy of Sciences 731:257-261, Sept. 7, 1994.
  71. Evans MI, Ebrahim SAD, Berry SM, Holzgreve W, Isada NB, Quintero R, Johnson MP. Fluorescent in situ hybridization utilization for high risk prenatal diagnosis: a trade-off among speed, expense, and inherent limitations of chromosome specific probes. American Journal of Obstetrics & Gynecology 171(4):1055-1057, Oct. 1994.
  72. Qureshi F, Jacques SM, Johnson MP, Reichler A, Evans MI. Neuroblastoma in situ in a fetus with a de novo unbalanced translocation 3:10. American Journal of Medical Genetics 53(1):24-28, Oct. 15, 1994.
  73. Isada NB, Hume RF Jr, Reichler A, Johnson MP, Klinger KW, Evans MI, Ward BE. Fluorescent in situ hybridization (FISH) and second trimester sonographic anomalies: Uses and limitations. Fetal Diagnosis & Therapy 9(6):367-370, Nov./Dec. 1994.
  74. Evans MI, Hoffman EP, Cadrin C, Johnson MP, Quintero RA, Golbus MS. Fetal muscle biopsy: Collaborative experience with varied indications. Obstetrics & Gynecology 84(6):913-917, Dec. 1994.
  75. Quintero RA, Hume RF, Johnson MP, Smith C, Cotton DB, Romero R, Evans MI. Percutaneous fetal cystoscopy, and endoscopic fulguration of posterior urethral valves. American Journal of Obstetrics & Gynecology 172(1 Pt 1):206-209, Jan. 1995.
  76. Johnson MP, Michaelson JE, Barr M Jr, Treadwell MC, Hume RF Jr, Dombrowski MP, Johnson A, Bichalski J, Evans MI. Combining humerus and femur length for improved sonographic identification of pregnancies at increased risk for trisomy 21. American Journal of Obstetrics & Gynecology 172(4 Pt 1):1129-1135, Apr. 1995.
  77. Evans MI, Chik L, O'Brien JE, Chen B, Dvorin E, Ayoub M, Krivchenia EL, Ager JW, Johnson MP, Sokol RJ. MOMs and DADs: Improved specificity and cost effectiveness of biochemical screening for aneuploidy with DADs. American Journal of Obstetrics & Gynecology 172(4 Pt 1):1138-1147, Apr. 1995.
  78. Evans MI, Krivchenia EL, Johnson MP, Quintero R, King M, Pegoraro E, Hoffman EP. In utero fetal muscle biopsy alters diagnosis and carrier risks in Duchenne and Becker muscular dystrophy. Fetal Diagnosis & Therapy 10(2):71-75, Apr. 1995.
  79. Qureshi F, Jacques SM, Johnson SF, Johnson MP, Evans MI, Yang SS: Histopathology of fetal diastrophic dysplasia. American Journal of Medical Genetics 56(3):300-303, Apr. 10, 1995.
  80. Campbell SA, Johnson MP, Uhlmann WR, Duquette D, Evans MI. Pregnancy outcome when both members of a couple have balanced translocations. Obstetrics & Gynecology 85(5 Pt 2):844-846, May 1995.
  81. Berry SM, Lecolier B, Smith RS, Bercau G, Dombrowski MP, Puder KS, Kithier K, Bidat L, Johnson MP, Cotton DB. Fetal serum beta-2 microglobulin is a possible predictor of neonatal renal function. Lancet 345(8960):1277-1278, May 20, 1995.
  82. Evans MI, Quintero RA, King M, Qureshi F, Johnson MP. Endoscopically assisted, ultrasound guided fetal muscle biopsy. Fetal Diagnosis & Therapy 10(3):167-172, May/June 1995.
  83. Hume Jr. RF, Drugan A, Ebrahim SAD, Johnson MP, Isada NB, Reichler A, Evans MI. The role of ultrasonography (US) in pregnancies with marker chromosome (MC) aneuploidy. Fetal Diagnosis & Therapy 10(3):183-186, May/June 1995.
  84. Evans MI, Littman L, St. Louis L, LeBlanc L, Addis J, Johnson MP, Moghissi KS: Evolving patterns of iatrogenic multifetal pregnancy generation: implications for aggressiveness of infertility treatments. American Journal of Obstetrics & Gynecology 172(6):1750-1753, June 1995.
  85. Johnson MP, Corsi P, Bradfield W, Hume RF, Smith C, Flake AW, Qureshi F, Evans MI: Sequential urinalysis improves evaluation of fetal renal function in obstructive uropathy. American Journal of Obstetrics & Gynecology 173(1):59-65, July 1995.
  86. Quintero RA, Johnson MP, Romero R, Smith C, Arias F, Guevara-Zuloaga F, Cotton DB, Evans MI. In-utero percutaneous cystoscopy in the management of fetal lower obstructive uropathy. Lancet 346(8974):537-540, Aug. 26, 1995.
  87. Dombrowski MP, Tomlinson MW, Bottoms SF, Johnson MP, Sokol RJ: Computer-generated admission forms have greater accuracy. American Journal of Obstetrics & Gynecology 173(3 Pt 1):847-848, Sept. 1995.
  88. Hume RF, Kilmer-Ernst P, Wolfe HM, Ebrahim SAD, Treadwell MC, Johnson MP, Evans MI. Prenatal cytogenetic abnormalities: Correlations of structural rearrangements and ultrasound detected fetal anomalies. American Journal of Obstetrics & Gynecology 173(4):1334-1336, Oct. 1995.
  89. Quintero RA, Johnson MP, Arias F, Cortez K, Carreno C, Romero R, Evans MI. In utero sonographic diagnosis of vesicoureteral reflux by percutaneous vesicoinfusion. Ultrasound in Obstetrics & Gynecology 6(6):386-389, Dec. 1995.
  90. Hume RF, Drugan A, Reichler A, Lampinen J, Johnson MP, Evans MI. Aneuploidy among prenatally detected neural tube defects. American Journal of Medical Genetics 61(2):171-173, Jan. 11, 1996.
  91. Drugan A, Johnson MP, Reichler A, Hume RF, Bronshtein M, Itskovicz-Eldor J, Evans MI. Increased amniotic fluid alpha-fetoprotein in patients with fetal nuchal edema. Fetal Diagnosis & Therapy 11(1):6-8, Jan./Feb. 1996.
  92. Drugan A, O'Brien JE, Dvorin E, Krivchenia E, Johnson MP, Sokol RJ, Evans MI. Multiple marker screening in multifetal gestations: Prediction of adverse pregnancy outcomes. Fetal Diagnosis & Therapy 11(1):16-19, Jan./Feb. 1996.
  93. Tomlinson M, Johnson MP, Goncalves L, King M, Freedman A, Smith C, Reichler A, Evans MI. Correction of hemodynamic abnormalities by vesicoamniotic shunting in familial congenital megacystis. Fetal Diagnosis & Therapy 11(1):46-49, Jan./Feb. 1996.
  94. Evans MI, Chik L, O'Brien JE, Dvorin E, Johnson MP, Krivchenia E, Sokol RJ. Logistic regression generated probability estimates for Trisomy 21 outcomes from serum AFP and beta-hCG: simplifi-cation with increased specificity. Journal of Maternal Fetal Medicine 5(1):1-6, Jan./Feb. 1996.
  95. Evans MI, Dommergues M, Wappner RJ, Goldberg JD, Lynch L, Zador IE, Carpenter R, Timor-Tritsch I, Brambati B, Nicolaides KH, Dumez Y, Monteagudo A, Johnson MP, Golbus MS, Brambati L, Polak SM, Berkowitz RL. International collaborative experience of 1789 patients having multifetal pregnancy reduction: a plateauing of risks and outcomes. Journal of the Society of Gynecologic Investigation 3(1):20-22, Jan./Feb. 1996.
  96. Evans MI, O'Brien JE, Dvorin E, Krivchenia EL, Drugan A, Hume RF, Johnson MP. Similarity of insulin dependent diabetics' (IDD) and non-insulin dependent diabetics' (NIDD) levels of beta-hCG and unconjugated estriol with controls: no need to adjust as with AFP. Journal of the Society of Gynecologic Investigation 3(1):23-26, Jan./Feb. 1996.
  97. Evans MI, Sobecki MA, Krivchenia EL, Duquette DA, Johnson MP, Drugan A, Hume RF. Parental decisions to terminate/continue following abnormal cytogenetic prenatal diagnosis: “What” is still more important than “when.” American Journal of Medical Genetics 61(4):353-355, Feb. 2, 1996.
  98. Dombrowski MP, Isada NB, Johnson MP, Berry SM. Modified stylet technique for tenting of amniotic membranes. Obstetrics & Gynecology 87(3):455-456, Mar. 1996.
  99. Nugent CA, LeBlanc L, Johnson MP, Hume RF, Evans MI. Persistence of partial molar placenta and severe preeclampsia after selective termination in a twin pregnancy. Obstetrics & Gynecology 87(5 Pt 2):829-831, May 1996.
  100. Evans MI, Hume RF, Johnson MP, Treadwell MC, Krivchenia E, Zador IE, Sokol RJ. Integration of genetics and ultrasound in prenatal diagnosis: Just looking is not enough. American Journal of Obstetrics & Gynecology 174(6):1926-30, June 1996.
  101. Quintero RA, Romero R, Reich H, Goncalves L, Johnson MP, Carreno C, Evans MI. In utero percutaneous umbilical-cord ligation in the management of complicated monochorionic multiple gestations. Journal of Ultrasound in Obstetrics and Gynecology 8(1):16-22, July 1996.
  102. Quintero RA, Reich H, Romero R, Johnson MP, Goncalves L, Evans MI. In utero endoscopic devascularization of a large placental chorioangioma. Journal of Ultrasound in Obstetrics and Gynecology 8(1):48-52, July 1996.
  103. Freedman AL, Bukowski TP, Smith CA, Evans MI, Quintero R, Gonzales R, Johnson MP. Fetal ther-apy for obstructive uropathy: Diagnosis specific outcomes. Urology 156(2 Pt 2):720-724, Aug. 1996.
  104. Drugan A, Johnson MP, Reichler A, Hume RF, Itskovicz-Eldor J, Evans MI. Second trimester minor ultrasound anomalies: Impact on the risk of aneuploidy associated with advanced maternal age. Obstetrics & Gynecology 88(2):203-206, Aug. 1996.
  105. Drugan A, Reichler A, Bronstein M, Johnson MP, Sokol RJ, Ebrahim SAD, Evans MI. Abnormal biochemical serum screening versus second trimester ultrasound-detected minor anomalies are predictors of aneuploidy in low risk patients. Fetal Diagnosis & Therapy 11(5):301-305, Sept./Oct. 1996.
  106. Qureshi F, Jacques SM, Seifman B, Quintero RA, Evans MI, Smith C, Johnson MP. In utero fetal urine analysis and renal histology do correlate with outcome in fetal obstructive uropathies. Fetal Diagnosis & Therapy 11(5):306-312, Sept./Oct. 1996.
  107. Landwehr JB, Johnson MP, Hume RF, Sokol RJ, Yaron Y, Evans MI. Abnormal nuchal findings on screening ultrasound: Aneuploidy stratification based on ultrasound anomaly and gestational age at detection. American Journal of Obstetrics & Gynecology 175(4 Pt 1):995-999, Oct. 1996.
  108. Brown CL, Colden KA, Hume RF, Johnson MP, Treadwell MC, Drugan A, Lampinen J, Evans MI. Faint or positive amniotic fluid acetylcholinesterase with a normal ultrasound. American Journal of Obstetrics & Gynecology 175(4 Pt 1):1000-1003, Oct. 1996.
  109. Ahmad FK, Sherman SJ, Hagglund KH, Krivchenia E, Johnson MP. Isolated unilateral fetal pleural effusion: The role of sonographic surveillance and in utero therapy. Fetal Diagnosis & Therapy 11(6):383-389, Nov./Dec. 1996.
  110. Lanouette JM, Duquette DA, Jacques SM, Qureshi F, Johnson MP, Berry SM. Prenatal diagnosis of fetal herpes simplex infection. Fetal Diagnosis & Therapy 11(6):414-416, Nov./Dec. 1996.
  111. Flake AW, Puck JM, Almieda-Porada G, Roncarolo MG, Evans MI, Johnson MP, Harrison D, Littman L, Johnson J, Zanjani ED. Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. New England Journal of Medicine 335(24):1806-1810, Dec. 12, 1996.
  112. Freedman AL, Qureshi F, Shapiro E, Lepor H, Jacques SM, Evans MI, Smith CA, Gonzales R, Johnson MP. Smooth muscle development in the obstructed fetal bladder. Urology 49(1):104-107, Jan. 1997.
  113. Evans MI, Duquette DA, Rinaldo P, Bawle E, Rosenblatt DS, Whitty J, Quintero RA, Johnson MP. Modulation of B12 dosage and response in fetal treatment of methylmalonic aciduria (MMA): Titration of treatment dose to serum and urine MMA. Fetal Diagnosis & Therapy 12(1):21-23, Jan./Feb. 1997.
  114. O’Brien JE, Dvorin E, Drugan A, Johnson MP, Yaron Y, Evans MI. Race-ethnicity-specific variation in multiple-marker biochemical screening: alpha-fetoprotein, hCG, and estriol. Obstetrics & Gynecology 89(3):355-358, Mar. 1997.
  115. Chung IB, Kramer JA, Johnson MP, Evans MI, Krawetz SA. The use of cloned repetitive sequences as competitors for southern hybridization to detect single copy sequences. Biomolecular Engineering 14(1):13-15, Mar. 1997.
  116. Hallak M, O'Brien JE, Isada NB, Johnson MP, Drugan A, Evans MI. Maternal thyroid function does not alter maternal serum alpha-fetoprotein interpretation. Journal of Maternal Fetal Medicine 6(2):115-117, Mar./Apr. 1997.
  117. Qureshi F, Jacques SM, Johnson MP, Hume RF, Kramer RL, Yaron Y, Evans MI. Trisomy 21 placentas: Histopathological and immunohistochemical findings using proliferating cell nuclear antigen (PCNA) Fetal Diagnosis & Therapy 12(4):210-215, July/Aug. 1997.
  118. Hume RF Jr, Martin LS, Bottoms SF, Hassan SS, Banker-Collins K, Tomlinson M, Johnson MP, Evans MI. Vascular disruption birth defects and history of prenatal cocaine exposure: A case control study. Fetal Diagnosis & Therapy 12(5):292-295, Sept./Oct. 1997.
  119. Kramer RL, Johnson MP, Qureshi F, Jacques SM, Yaron Y, Evans MI. Concordance for cloacal dysgenesis. Fetal Diagnosis & Therapy 12(5):279-282, Sept./Oct. 1997.
  120. Drugan A, Yaron Y, Murphy J, Ebrahim SA, Kramer RL, Johnson MP, Evans MI. No effect of fetal sex on amniotic fluid alpha-fetoprotein. Fetal Diagnosis & Therapy 12(5):301-303, Sept./Oct. 1997.
  121. Kramer RL, Yaron Y, Johnson MP, Evans MI, Treadwell MC, Wolfe HM. Differences in measurements of the atria of the lateral ventricle: Does gender matter? Fetal Diagnosis & Therapy 12(5):304-305, Sept./Oct. 1997.
  122. Evans MI, Hume RF, Polak S, Yaron Y, Drugan A, Diamond MP, Johnson MP. The geriatric gravida: Multifetal pregnancy reduction (MFPR) donor eggs and aggressive infertility treatments. American Journal of Obstetrics & Gynecology 177(4):875-878, Oct. 1997.
  123. Chik L, Spencer K, Johnson MP, Ayoub M, Krivchenia EL, Dombrowski MP, Evans MI. Precise Gaussian distribution functions of maternal serum AFP and free bHCG for trisomy 21 (T21) biochemical screening. American Journal of Obstetrics & Gynecology 177(4):882-886, Oct. 1997.
  124. O'Brien JE, Dvorin E, Yaron Y, Ayoub M, Johnson MP, Hume RF Jr, Evans MI. Differential increases in AFP, hCG, and uE3 in twin pregnancies: impact on attempts to quantify Down syn-drome screening calculations. American Journal of Medical Genetics 73(2):109-12, Dec 12, 1997.
  125. Kramer RL, O’Brien JE, Critchfield G, Yaron Y, Ayoub M, Lewis PS, Johnson MP, Evans MI. The effect of adjustment of maternal serum a-fetoprotein (MSAFP) levels in insulin-dependent diabetes mellitus (IDDM). American Journal of Medical Genetics 75(2):176-178, Jan. 13, 1998.
  126. Yaron Y, Hamby DD, O’Brien JE, Critchfield G, Leon J, Ayoub M, Johnson MP, Evans MI. The combination of elevated maternal serum alpha-fetoprotein (MSAFP) and low estriol is highly predictive of anencephaly. American Journal of Medical Genetics 75(3):297-299, Jan. 23, 1998.
  127. Bryant-Greenwood PK, O’Brien JE, Huang X, Yaron Y, Ayoub M, Johnson MP, Evans MI. Maternal weight differences do not explain ethnic differences in biochemical screening. Fetal Diagnosis & Therapy 13(1):46-48, Jan./Feb. 1998.
  128. McLean LK, Evans MI, Carpenter RJ, Johnson MP, Goldberg JD. Genetic amniocentesis (AMN) following multifetal pregnancy reduction (MFPR) does not increase the risk of pregnancy loss. Prenatal Diagnosis 18(2):186-188, Feb. 1998.
  129. Bazzett LB, O’Brien JE, Critchfield G, Kramer RL, Yaron Y, Ayoub M, Johnson MP, Evans MI. Fetal gender impact on multiple marker screening results. American Journal of Medical Genetics 76(5):369-371, Apr. 13, 1998.
  130. Doss BJ, Jolly S, Qureshi F, Jacques SM, Evans MI, Johnson MP, Lampinen J, Kupsky WJ. Neuropathologic findings in a case report of OFDS Type VI (Varadi Syndrome). American Journal of Medical Genetics 77(1):38-42, Apr. 28, 1998.
  131. Leonardi MR, Lanouette JM, Landwehr JB, Johnson MP, Wolfe HM, Evans MI. The apparently isolated choroid plexus cyst: importance of minor abnormalities in predicting the risk for aneuploidy. Fetal Diagnosis & Therapy 13(1):49-52, Jan./Feb. 1998.
  132. Yaron Y, Kramer JA, Gyi K, Ebrahim SA, Evans MI, Johnson MP, Krawetz SA. Centromere sequences localize to the nuclear halo of human spermatozoa. International Journal of Andrology 21(1):13-18, Feb. 1998.
  133. Qureshi F, Jacques SM, Yaron Y, Kramer RL, Evans MI, Johnson MP. Prenatal diagnosis of cloacal dysgenesis sequence: differential diagnosis from other forms of fetal obstructive uropathy. Fetal Diagnosis & Therapy 13(2):69-74, Mar./Apr. 1998.
  134. Brady TB, Lidums S, Yaron Y, Evans MI, Johnson MP, Kramer RL. Pastoral care utilization among women electing pregnancy termination for fetal anomalies. Fetal Diagnosis & Therapy 13(2):123-126, Mar./Apr. 1998.
  135. Yaron Y, Johnson KD, Bryant-Greenwood PK, Kramer RL, Johnson MP, Evans MI. Selective termination and elective reduction in twin pregnancies: 10 years experience at a single center. Human Reproduction 13(8):2301-2304, Aug. 1998.
  136. Kramer RL, Jarve RK, Yaron Y, Johnson MP, Lampinen J, Kasperski SB, Evans MI. Determinants of parental decisions after the prenatal diagnosis of Down syndrome. American Journal of Medical Genetics 79(3):172-174, Sept. 23, 1998.
  137. Feldman B, Dvorin E, Phillips T, Kramer RL, Johnson MP, Evans MI. 2nd-trimester maternal serum marker results are not altered by delayed analysis. Fetal Diagnosis & Therapy 13(5):302-304, Sept./Oct. 1998.
  138. Sokol AI, Kramer RL, Yaron Y, O’Brien JE, Muller F, Johnson MP, Evans MI. Age-specific variation in aneuploidy incidence among biochemical screening programs. American Journal of Obstetrics & Gynecology 179(4):971-973, Oct. 1998.
  139. Kramer R, Feldman B, Ebrahim SA, Kasperski SB, Johnson MP, Evans MI. Molecular cytogenetic analysis of a de novo 5q31q33 deletion associated multiple congenital anomalies: case report. American Journal of Medical Genetics 82(2):143-145, Jan. 15, 1999.
  140. Quintero RA, Johnson MP, Mendoza G, Evans MI. Ontogeny of clenched-hand development in trisomy 18 fetuses: A serial transabdominal fetoscopic observation. Fetal Diagnosis & Therapy 14(2):68-70, Mar./Apr. 1999.
  141. Drugan A, Bronshtein M, Itskovitz-Eldor J, Johnson MP, Evans MI. Ontogeny of isolated ultra-sound markers for fetal aneuploidy. Fetal Diagnosis & Therapy 14(5):266-269, Sept./Oct. 1999.
  142. Sutton LN, Adzick NS, Bilaniuk LT, Johnson MP, Crombleholme TM, Flake AW. Improvement in hindbrain herniation demonstrated by serial fetal magnetic resonance imaging following fetal surgery for myelomeningocele. JAMA 282(19):1826-1831, Nov. 17, 1999.
  143. Yaron Y, Kramer RL, Feldman B, Kasperski SB, Vo T, Feldman GL, Johnson MP, Evans MI, Ebrahim SA. Prenatal diagnosis of 46,XY/46,XX mosaicism: A case report. American Journal of Medical Genetics 84(1):12-14, May 1999.
  144. Yaron Y, Bryant-Greenwood PK, Dave N, Moldenhauer JS, Kramer RL, Johnson MP, Evans MI. Multifetal pregnancy reductions of triplets to twins: Comparison with nonreduced triplets and twins. American Journal of Obstetrics & Gynecology 180(5):1268-1271, May 1999.
  145. Evans MI, Henry GP, Miller WA, Bui TH, Snidjers RJ, Wapner RJ, Miny P, Johnson MP, Peakman D, Johnson A, Nicolaides K, Holzgreve W, Ebrahim SA, Babu R, Jackson L. International, collaborative assessment of 146,000 prenatal karyotypes: Expected limitations if only chromosome-specific probes and fluorescent in-situ hybridization are used. Human Reproduction 14(5):1213-1216, May 1999.
  146. Feldman B, Hassan S, Kramer RL, Kasperski SB, Evans MI, Johnson MP. Amnioinfusion in the evaluation of fetal obstructive uropathy: The effect of antibiotic prophylaxis on complication rates. Fetal Diagnosis & Therapy 14(3):172-175, May/June 1999.
  147. Drugan A, Yaron Y, Zamir R, Ebrahim SA, Johnson MP, Evans MI. Differential effect of advanced maternal age on prenatal diagnosis of trisomies 13, 18, and 21. Fetal Diagnosis & Therapy 14(3):181-184, May/June 1999.
  148. Feldman B, Yaron Y, Critchfield G, Leon J, O’Brien JE, Johnson MP, Evans MI. Distribution of neural tube defects as a function of maternal weight: No apparent correlation. Fetal Diagnosis & Therapy 14(3):185-189, May/June 1999.
  149. Brady TB, Kramer RL, Qureshi F, Feldman B, Kupsky WJ, Johnson MP, Evans MI. Ontogeny of recurrent hydrocephalus: Presentation in three fetuses in one consanguineous family. Fetal Diagnosis & Therapy 14(4):198-200, July/Aug. 1999.
  150. Freedman AL, Johnson MP, Smith CA, Gonzalez R, Evans MI. Long-term outcome in children after antenatal intervention for obstructive uropathies. The Lancet 354(9176):374-377, July 31, 1999.
  151. Wu AG, Michejda M, Mazumder A, Meehan KR, Menendez FA, Tchabo JG, Slack R, Johnson MP, Bellanti JA. Analysis and characterization of hematopoietic progenitor cells from fetal bone marrow, adult bone marrow, peripheral blood, and cord blood. Pediatric Research 46(2):163-169, Aug. 1999.
  152. Evans MI, Goldberg JD, Horenstein J, Wapner RJ, Ayoub MA, Stone J, Lipitz S, Achiron R, Holzgreve W, Brambati B, Johnson A, Johnson MP, Shalhoub A, Berkowitz RL. Selective termination for structural, chromosomal, and mendelian anomalies: International experience. American Journal of Obstetrics & Gynecology 181(4):893-897, Oct. 1999.
  153. Yaron Y, Cherry M, Kramer RL, O’Brien JE, Hallak M, Johnson MP, Evans MI. Second-trimester maternal serum marker screening: Maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome. American Journal of Obstetrics & Gynecology 181(4):968-974, Oct 1999.
  154. Feldman B, Ebrahim SAD, Hazan SL, Gyi K, Johnson MP, Johnson A, Evans MI. Routine prenatal diagnosis of aneuploidy by FISH studies in high risk pregnancies. American Journal of Medical Genetics 90(3):233-238, Jan. 31, 2000.
  155. Carreno C, King M, Johnson MP, Yaron Y, Diamond M, Bush D, Evans MI. Treatment of heterotopic cervical and intrauterine pregnancy. Fetal Diagnosis & Therapy 15(1):1-3, Jan./Feb. 2000.
  156. Pryde PG, Hallak M, Lauria M, Littman L, Bottoms S, Johnson MP, Evans MI. Severe oligohydramnios with intact membranes: An indication for diagnostic amnioinfusion. Fetal Diagnosis & Therapy 15(1):46-49, Jan./Feb. 2000.
  157. Seubert DE, Feldman B, Krivchenia EL, Evans MI, Barki J, Johnson MP. Molecular and fetal tissue biopsy capabilities are needed to maximize prenatal diagnosis of junctional epidermolysis bullosa (JEB): Fetal skin biopsy using a 2mm microendoscope. Fetal Diagnosis & Therapy 15(2):89-92, Mar./Apr. 2000.
  158. Qureshi F, Yang Y, Jaques SM, Johnson MP, Naparstek Y, Ulmansky R, Schuger L. Anti-DNA antibodies cross-reacting with laminin inhibit trophoblast attachment and migration: implications for recurrent pregnancy loss in SLE patients. American Journal of Reproductive Immunology 44(3):135-142, Sept. 2000.
  159. Flake AW, Crombleholme TM, Johnson MP, Howell LJ, Adzick NS. Treatment of severe congenital diaphragmatic hernia by fetal tracheal occlusion. Clinical experience in fifteen cases. American Journal of Obstetrics & Gynecology 183(3):1059-1066, Nov. 2000.
  160. Walsh DS, Hubbard AM, Olutoye OO, Howell LJ, Crombleholme TM, Flake AW, Johnson MP, Adzick NS. Assessment of fetal lung volumes and liver herniation with magnetic resonance imaging in congenital diaphragmatic hernia. American Journal of Obstetrics & Gynecology 183(5):1067-1069, Nov. 2000.
  161. Qureshi F, Jacques SM, Feldman B, Doss BJ, Evans MI, Johnson MP. Fetal obstructive uropathy associated with trisomy syndromes. Fetal Diagnosis & Therapy 15(6):342-347, Nov./Dec. 2000.
  162. Galinkin JL, Gaiser RR, Cohen DE, Crombleholme TM, Johnson MP, Kurth CD. Anesthesia for fetoscopic fetal surgery: Twin reverse arterial perfusion sequence and twin-twin transfusion syndrome. Anesthesia & Analgesia 91(6):1394-1397, Dec. 2000.
  163. MacKenzie TC, Guttenberg ME, Nisenbaum HL, Johnson MP, Adzick NS. A fetal lung lesion consisting of bronchogenic cyst, bronchopulmonary sequestration, and congenital cystic adenoma-toid malformation: The missing link? Fetal Diagnosis & Therapy 16(4):193-195, July/Aug. 2001.
  164. Austin JC, Canning DA, Johnson MP, Flake AW, Carr MC. Vesicoamniotic shunting in a female fetus with prune belly syndrome. Journal of Urology 166(6):2382, Dec. 2001.
  165. Bouchard S, Johnson MP, Flake AW, Howell LJ, Meyers L, Adzick NS, Crombleholme TM. The EXIT procedure: Experience and outcome in 31 cases. Journal of Pediatric Surgery 37(3): 418-426, Mar. 2002.
  166. Cohen MS, Rychik J, Bush DM, Tian ZY, Howell LJ, Adzick NS, Flake AW, Johnson MP, Spray TL, Crombleholme TM. Influence of congenital heart disease on survival in children with congenital diaphragmatic hernia. Journal of Pediatrics 141(1):25-30, July 2002.
  167. Hutcheson JC, Canning DA, Hubbard AM, Johnson MP, Carr MC. Magnetic resonance imaging of fetal urinoma. Urology 60(4):697, Oct. 2002.
  168. Tulipan N, Sutton LN, Bruner JP, Cohen BM, Johnson M, Adzick NS. The effect of intrauterine Myelomeningocele repair on the incidence of shunt-dependent hydrocephalus. Pediatric Neurosurgery 38(1):27-33, Jan. 2003.
  169. Keswani SG, Johnson MP, Hori S, Howell LJ, Hedrick HL, Flake AW, Wilson RD, Adzick NS, Crombleholme TM. In utero limb salvage: Fetoscopic release of amniotic bands for threatened limb amputation. Journal of Pediatric Surgery 38(6):848-851, June 2003.
  170. Lim FY, Crombleholme TM, Hedrick HL, Flake AW, Johnson MP, Howell LJ, Adzick NS. Congenital high airway obstruction syndrome: Natural history and management. Journal of Pediatric Surgery 38(6):940-945, June 2003.
  171. Sutton LN, Adzick NS, Johnson MP. Fetal surgery for myelomeningocele. Childs Nervous System 19(7-8):587-591, Aug. 2003.
  172. Johnson MP, Sutton LN, Rintoul N, Crombleholme TM, Flake AW, Howell LJ, Hedrick HL, Wilson RD, Adzick NS. Fetal myelomeningocele repair: Short term clinical outcomes. American Journal of Obstetrics & Gynecology 189(2):482-487, Aug. 2003.
  173. Wilson RD, Johnson MP, Crombleholme TM, Flake AW, Hedrick HL, King M, Howell LJ, Adzick NS. Chorioamniotic membrane separation following open fetal surgery: pregnancy outcome. Fetal Diagnosis & Therapy 18(5):314-320, Sept./Oct. 2003.
  174. Olutoye OO, Johnson MP, Coleman BG, Crombleholme TM, Adzick NS, Flake AW. Abnormal umbilical cord Dopplers may predict impending demise in fetuses with sacrococcygeal teratoma. A report of 2 cases. Fetal Diagnosis & Therapy 18(6):428-31, Nov./Dec. 2003.
  175. Olutoye OO, Johnson MP, Coleman BG, Crombleholme TM, Adzick NS, Flake AW. Abnormal umbilical cord Doppler sonograms may predict impending demise in fetuses with sacrococcygeal teratoma. A report of two cases. Fetal Diagnosis & Therapy 19(1):35-39, Jan./Feb. 2004.
  176. Hedrick HL, Crombleholme TM, Flake AW, Nance ML, von Allmen D, Howell LJ, Johnson MP, Wilson RD, Adzick NS. Right congenital diaphragmatic hernia: Prenatal assessment and outcomes. Journal of Pediatric Surgery 39(3):319-323, Mar. 2004.
  177. Hedrick HL, Flake AW, Crombleholme TM, Howell LJ, Johnson MP, Wilson RD, Adzick NS. Sacrococcygeal teratoma: Prenatal assessment, fetal intervention, and outcome. Journal of Pediatric Surgery 39(3):430-438, Mar. 2004.
  178. Wilson RD, Baxter JK, Johnson MP, King M, Kasperski S, Crombleholme TM, Flake AW, Hedrick HL, Howell LJ, Adzick NS. Thoracoamniotic shunts: Fetal treatment of pleural effusions and congenital cystic adenomatoid malformations. Fetal Diagnosis & Therapy 19(5):413-420, Sept./Oct. 2004.
  179. Wilson RD, Johnson MP, Flake AW, Crombleholme TM, Hedrick HL, Wilson J, Adzick NS. Reproductive outcomes following pregnancy complicated by maternal-fetal surgery. American Journal of Obstetrics & Gynecology 191(4):1430-1436, Oct. 2004.
  180. Danzer E, Johnson MP, Wilson RD, Flake AW, Hedrick HL, Sutton LN, Adzick NS. Fetal head biometry following in utero repair of myelomeningocele. Ultrasound in Obstetrics & Gynecology 24(6):606-611, Nov. 2004.
  181. Merchant AM, Hedrick HL, Johnson MP, Wilson RD, Crombleholme TM, Howell LJ, Adzick NS, Flake AW. Management of fetal mediastinal teratoma. Journal of Pediatric Surgery 40(1):228-231, Jan. 2005.
  182. Keswani SG, Crombleholme TM, Pawel BR, Johnson MP, Flake AW, Hedrick HL, Howell LJ, Wilson RD, Davis GH, Adzick NS. Prenatal diagnosis and management of mainstem bronchial atresia. Fetal Diagnosis & Therapy 20(1):74-78, Jan./Feb. 2005.
  183. Hedrick HL, Flake AW, Crombleholme TM, Howell LJ, Johnson MP, Wilson RD, Adzick NS. The ex utero intrapartum therapy procedure for high-risk fetal lung lesions. Journal of Pediatric Surgery 40(6):1038-1044, June 2005.
  184. Keswani SG, Crombleholme TM, Rychik J, Tian Z, MacKenzie TC, Johnson MP, Wilson RD, Flake AW, Hedrick HL, Howell LJ, Adzick NS. Impact of continuous intraoperative monitoring on outcomes in open fetal surgery. Fetal Diagnosis & Therapy 20(4):316-320, July/Aug. 2005.
  185. Biard JM, Johnson MP, Carr MC, Wilson RD, Hedrick HL, Pavlock C, Adzick NS. Long-term outcomes in children treated by prenatal vesicoamniotic shunting for lower urinary tract obstruction. Obstetrics & Gynecology 106(3):503-508, Sept. 2005.
  186. Fogel MA, Wilson RD, Flake AW, Johnson M, Cohen D, McNeal G, Tian ZY, Rychik J. A new method of functional assessment of the fetal heart using a novel application of “real time” cardiac magnetic resonance imaging. Fetal Diagnosis & Therapy 20(5):476-480, Sept./Oct. 2005.
  187. Peranteau WH, Ganguly A, Steinmuller L, Thornton P, Johnson MP, Howell LJ, Stanley CA, Adzick NS. Prenatal diagnosis and postnatal management of diffuse congenital hyperinsulinism: A case report. Fetal Diagnosis & Therapy 21(6):515-518, 2006.
  188. Liechty KW, Hedrick HL, Hubbard AM, Johnson MP, Wilson RD, Ruchelli ED, Howell LJ, Crombleholme TM, Flake AW, Adzick NS. Severe pulmonary hypoplasia associated with giant cervical teratomas. Journal of Pediatric Surgery 41(1):230-233, Jan. 2006.
  189. Chen SC, Simon EM, Haselgrove JC, Bilaniuk LT, Sutton LN, Johnson MP, Shera DM, Zimmerman RA. Fetal posterior fossa volume: Assessment with MR imaging Radiology 238(3):997-1003, Mar. 2006.
  190. Johnson MP, Gerdes M, Rintoul N, Pasquariello P, Melchionni J, Sutton LN, Adzick NS. Maternal-fetal surgery for myelomeningocele: Neurodevelopmental outcomes at two years of age. American Journal of Obstetrics & Gynecology 194(4):1145-1152, Apr. 2006.
  191. Danzer E, Hubbard AM, Hedrick HL, Johnson MP, Wilson RD, Howell LJ, Crombleholme TM, Flake AW, Adzick NS. Diagnosis and characterization of fetal sacrococcygeal teratoma with prenatal MR imaging. American Journal of Roentgenology 187(4):W350-356, Oct. 2006.
  192. Danzer E, Johnson MP, Bebbington MW, Simon EM, Wilson RD, Bilaniuk LT, Sutton LN, Adzick NS. Fetal head biometry assessed by fetal magnetic resonance imaging following in utero myelomeningocele repair. Fetal Diagnosis & Therapy 22(1):1-6, 2007.
  193. Wilson RD, Johnson MP, Bebbington MW, Flake AW, Hedrick HL, Sutton LN, Adzick NS. Does a myelomeningocele sac compared to no sac result in decreased leg function following maternal fetal surgery for spina bifida apera? Fetal Diagnosis & Therapy 22(5):348-351, 2007.
  194. Netta DA, Wilson RD, Visintainer P, Johnson MP, Hedrick HL, Flake AW, Adzick NS. Gastroschisis: growth and prenatal surveillance. Fetal Diagnosis & Therapy 22(5):352-357, 2007.
  195. Peranteau WH, Wilson RD, Liechty KW, Johnson MP, Bebbington MW, Hedrick HL, Flake AW, Adzick NS. Effect of maternal betamethasone administration on prenatal congenital cystic adeno-matoid malformation growth and fetal survival. Fetal Diagnosis & Therapy 22(5):365-371, 2007.
  196. Merchant AM, Peranteau W, Wilson RD, Johnson MP, Bebbington MW, Hedrick HL, Flake AW, Adzick NS. Postnatal chest wall deformities after fetal thoracoamniotic shunting for congenital cystic adenomatoid malformation. Fetal Diagnosis & Therapy 22(6):435-439, 2007.
  197. Rychik J, Tian Z, Bebbington M, Xu F, McCann M, Mann S, Wilson RD, Johnson MP. The twin-twin transfusion syndrome: Spectrum of cardiovascular abnormality and development of a cardiovascular score to assess severity of disease. American Journal of Obstetrics & Gynecology 197(4):392.e1-8, Oct. 2007.
  198. Hedrick HL, Danzer E, Merchant A, Bebbington MW, Zhao H, Flake AW, Johnson MP, Liechty KW, Howell LJ, Wilson RD, Adzick NS. Liver position and lung-to-head ratio for prediction of extracorporeal membrane oxygenation and survival in isolated left congenital diaphragmatic hernia. American Journal of Obstetrics & Gynecology 197(4):422.e1-4, Oct. 2007.
  199. Husler MR, Wilson RD, Rychik J, Bebbington MW, Johnson MP, Mann SE, Hedrick HL, Adzick S. Prenatally diagnosed fetal lung lesions with associated conotruncal heart defects: Is there a genetic association? Prenatal Diagnosis 27(12):1123-1128, Dec. 2007.
  200. Peranteau WH, Merchant AM, Hedrick HL, Liechty KW, Howell LJ, Flake AW, Wilson RD, Johnson MP, Bebbington MW, Adzick NS. Prenatal course and postnatal management of peripheral bronchial atresia: Association with congenital cystic adenomatoid malformation of the lung. Fetal Diagnosis & Therapy 24(3):190-196, 2008.
  201. Kasperski SB, Brennan AM, Corteville JE, Finkel RS, Golden J, Johnson MP, Wilson RD. Utility of fetal muscle biopsy for diagnosis of nemaline myopathy. Fetal Diagnosis & Therapy 24(4):400-404, 2008.
  202. Tiblad E, Wilson RD, Carr M, Flake AW, Hedrick H, Johnson MP, Bebbington MW, Mann S, Adzick NS. OEIS sequence: A rare congenital anomaly with prenatal evaluation and postnatal outcome in six cases. Prenatal Diagnosis 28(2):141-147, Feb. 2008.
  203. Tsai AY, Liechty KW, Hedrick HL, Bebbington M, Wilson RD, Johnson MP, Howell LJ, Flake AW, Adzick NS. Outcomes after postnatal resection of prenatally diagnosed asymptomatic cystic lung lesions. Journal of Pediatric Surgery 43(3):513-517, Mar. 2008.
  204. Biard JM, Schwarz U, Davey MG, Danzer E, Johnson MP, Flake AW, Adzick NS, Hedrick HL. Main bronchus occlusion for treatment of congenital diaphragmatic hernia in fetal lambs. Journal of Pediatric Surgery 43(4):620-626, Apr. 2008.
  205. Badillo AT, Hedrick HL, Wilson RD, Danzer E, Bebbington MW, Johnson MP, Liechty KW, Flake AW, Adzick NS. Prenatal ultrasonographic gastrointestinal abnormalities in fetuses with gastroschisis do not correlate with postnatal outcomes. Journal of Pediatric Surgery 43(4):647-653, Apr. 2008.
  206. Danzer E, Davey MG, Kreiger PA, Ruchelli ED, Johnson MP, Adzick NS, Flake AW, Hedrick HL. Fetal tracheal occlusion for severe congenital diaphragmatic hernia in humans: A morphometric study of lung parenchyma and muscularization of pulmonary arterioles. Journal of Pediatric Surgery 43(10):1767-1775, Oct. 2008.
  207. Danzer E, Finkel RS, Rintoul NE, Bebbington MW, Schwartz ES, Zarnow DM, Adzick NS, Johnson MP. Reversal of hindbrain herniation after maternal-fetal surgery for myelomenin-gocele subsequently impacts on brain stem function. Neuropediatrics 39(6):359-362, Dec. 2008.
  208. Danzer E, Adzick NS, Rintoul NE, Zarnow DM, Simon Schwartz EM, Melchionni J, Flake AW, Sutton LN, Johnson MP. Intradural inclusion cysts following in utero myelomeningocele closure: Clinical implications and follow-up. Journal of Neurosurgery Pediatrics 2(6):406-413, Dec. 2008.
  209. Danzer E, Ernst LM, Rintoul NE, Johnson MP, Adzick NS, Flake AW. In utero meconium passage in fetuses and newborns with myelomeningocele. Journal of Neurosurgery Pediatrics 3(2):141-146, Feb. 2009.
  210. Peranteau WH, Heaton TE, Gu YC, Volk SW, Bauer TR, Alcorn K, Tuschong LM, Johnson MP, Hickstein DD, Flake AW. Haploidentical in utero hematopoietic cell transplantation improves phenotype and can induce tolerance for postnatal same-donor transplants in the canine leukocyte adhesion deficiency model. Biology of Blood & Marrow Transplantation 15(3):293-305, Mar. 2009.
  211. Kasperski SB, Brennan AM, Corteville JE, Finkel RS, Golden J, Johnson MP, Wilson RD. Utility of fetal muscle biopsy for diagnosis of nemaline myopathy. Fetal Diagnosis & Therapy 24(4):400-404, Apr. 2009.
  212. Danzer E, Gerdes M, Bebbington MW, Sutton LN, Melchionni J, Adzick NS, Wilson RD, Johnson MP. Lower extremity neuromotor function and ambulation potential following in utero myelomeningocele repair. Fetal Diagnosis & Treatment 25(1):47-53, 2009.
  213. Wilson RD, Hedrick H, Flake AW, Johnson MP, Bebbington MW, Mann S, Rychik J, Liechty K, Adzick NS. Sacrococcygeal teratoma: Prenatal surveillance, growth and pregnancy outcome. Prenatal Diagnosis 25(1):15-20, 2009.
  214. Mong A, Johnson AM, Kramer SS, Coleman BG, Hedrick HL, Kreiger P, Flake A, Johnson MP, Wilson RD, Adzick NS, Jaramillo D. Congenital high airway obstruction syndrome: MR/US findings, effect on management and outcome. Pediatr Radiol 2008;38(1):1171-1179.
  215. Huesler-Charles M, Wilson RD, Hori S, Coleman B, Bebbington MW, Mann SE, Adzick NS, Johnson MP. When is fetoscopic release of amniotic bands indicated? Review of outcome of cases treated in utero and selection criteria for fetal surgery. Prenatal Diagnosis 2009; 29(5):457-63.
  216. Husler MR, Danzer E, Sutton L, Johnson MP, Bebbington M, Adzick NS, Wilson RD. Prenatal diagnosis and postnatal outcome of spinal defects without Chiari II malformation. Prenatal Diagnosis 2009; 29(11):1050-7.
  217. Bebbington M, Tiblad E, Huesler-Charles M, Wilson R, Mann S, Johnson M. Outcomes in a cohort of patients with Stage I TTTS. Ultrasound Obstet Gynecol 2010; 36(1):48-51.
  218. Danzer E, Finkel R, Gerdes M, Simon Schwartz EM, Rintoul NN, Adzick NS, Johnson MP. The relationship of seizure activity and chronic epilepsy in early infancy and short-term neurodevelopmental outcome following fetal myelomeningocele closure. Neuropediatrics 2010; 41: 140-143.
  219. Rychik J, Szwast A, Natarajan S, Quartermain M, Donaghue DD, Combs J, Gaynor JW, Gruber PJ, Spray TL, Bebbington M, Johnson MP. Perinatal and early surgical outcome for the fetus with hypoplastic left heart syndrome: A five-year single institutional experience. Ultrasound Obstet Gynecol 2010; 36:465-470.
  220. Roybal JL, Liechty KW, Hedrick HL, Bebbington MW, Johnson MP, Coleman BG, Adzick NS, Flake AW. Predicting the severity of congenital high airway obstruction syndrome. J Ped Surg 2010; 45(8):1633-1639.
  221. Wilson RD, Lemerand K, Johnson MP, Flake AW, Bebbington M, Hedrick HL, Adzick NS. Reproductive outcomes in subsequent pregnancies after a pregnancy complicated by open maternal-fetal surgery (1996-2007). Am J Obstet Gynecol 2010; 203(3):209, e1-6.
  222. Danzer E, Gerdes M, Zarnow D, Bebbington M, Adzick NS, Johnson MP. Preschool neurodevelopmental outcomes in children following fetal myelomeningocele closure. Am J Obstet Gynecol 2010; 202(5):450, e1-9.
  223. Servaes S, Hernandez A, Gonzalez L, Victoria T, Johnson M, Jaramillo D, Edgar JC, Johnson A. Fetal MRI of clubfoot associated with myelomeningocele. Pediatr Radiol 2010; 40(2):1874-1879.
  224. Rychik J, McCann M, Tian Z, Bebbington M, Johnson MP. Fetal cardiovascular effects of lower urinary tract obstruction with giant bladder. Ultrasound Obstet Gynecol 2010; 36(6):682-686.
    Johnson MP, NAFTNet. The North American Fetal Therapy Network (NAFTNet): a new approach to collaborative research in fetal diagnosis and therapy. Sem Fetal & Neonatal Research 2010; 15(1):52-57.
  225. Peterson AL, Quartermain MD, Ades A, Salam A, Khalek N, Johnson MP, Rychik J. Impact of mode of delivery on perinatal hemodynamics in infants with hypoplastic left heart syndrome. J Pediatrics 2011; 159(1):64-69, 2011.
  226. Adzick NS, Thom EA, Spong CY, Brock III JW, Burrows PK, Johnson MP, Howell LJ, Farrell JA, Dabrowiak ME, Sutton LN, Gupta N, Tulipan NB, D’Alton ME, Farmer DL. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 2011; 364(11):993-1004.
  227. Danzer E, Gerdes M, Bebbington MW, Koh J, Adzick NS, Johnson MP. Fetal myelomeningocele surgery: Preschool functional status using the Functional Independence Measure for Children (WeeFIM). Child’s Nervous System 2011; 27(7):1083-1088.
  228. Roybal JL, Moldenhauer JS, Khalek N, Bebbington MW, Johnson MP, Hedrick HL, Adzick NS, Flake AW. Early delivery as an alternative management strategy for selected high-risk fetal sacrococcygeal teratomas. J Ped Surgery 2011; 46(7):1325-1332.
  229. Danzer E, Gerdes M, Bebbington MW, Koh J, Adzick NS, Johnson MP. Preschool neurobehavioral outcome following fetal myelomeningocele surgery. Fetal Diagnosis & Therapy 2011; 30(3):174-179.
  230. Victoria T, Bebbington MW, Danzer E, Flake AW, Johnson MP, Dinan D, Adzick NS, Hedrick HL. Use of magnetic resonance imaging in prenatal prognosis of the fetus with isolated congenital diaphragmatic hernia. Prenatal Diagnosis 2012; 32(8):715-723.
  231. Laje P, Johnson MP, Howell LJ, Bebbington MW, Hedrick HL, Flake AW, Adzick NS. Ex Utero Intrapartum Treatment (EXIT) in the Management of Giant Cervical Teratomas. J Ped Surgery 2012; 47(6):1208-16.
  232. Danzer E., Victoria T., Bebbington M.W., Siegle J., Rintoul N.E., Johnson M.P., Flake A.W., Adzick N.S., Hedrick H.L. Fetal MRI-calculated total lung volumes in the prediction of short-term outcome in giant omphalocele -preliminary findings. Fetal Diagnosis & Therapy 2012; 31:248-253.
  233. Laje P, Howell LJ, Johnson MP, Hedrick HL, Flake AW, Adzick NS. Perinatal management of congenital oropharyngeal tumors: the Ex Utero Intrapartum Treatment (EXIT) approach. J Ped Surgery, (in press).
  234. Moise KJ, Bebbington MW, Johnson A, Walker M, Johnson MP. The benefit of laser therapy for severe twin-twin transfusion. (Letter to the Editor). Am J Obstet Gynecol 2013; (in press).
  235. Peranteau WH, Moldenhauer JS, Khalek N, Martinez-Poyer JL, Howell LJ, Johnson MP, Flake AW, Adzick NS, Hedrick HL. Open fetal surgery for central bronchial atresia. Fetal Diagnosis & Treatment 2013; submitted.
  236. Moldenhauer JS, Johnson MP, Endo M, Khalek N, Bebbington MW. Maternal obesity and outcomes with laser therapy for twin twin transfusion syndrome. Am J Obstet Gynecol 2013; submitted.
  237. Moldenhauer JS, Endo M, Bebbington MW, Adzick NS, Flake AW, Hedrick HL, Johnson MP. Maternal morbidity associated with the Ex-Utero intrapartum treatment (EXIT) procedure. Am J Obstet Gynecol 2013; submitted.
  238. Bebbington MW, Victoria T, Danzer E, Hedrick H, Johnson MP, Moldenhauer JM, Khalek N, Adzick NS. Comparison of ultrasound and MRI parameters in predicting survival in isolated left sided congenital diaphragmatic hernia (CDH): What works best? Ultrasound Obstet Gynecol 2013; in press.
  239. Oliver ER, Coleman BG, Goff  DA, Horii SC, Howell LJ, Rychik J, Bebbington MW, Johnson MP. Twin reverse arterial perfusion (TRAP) sequence: A new method of parabiotic twin mass estimation correlated with pump twin compromise.
Reviews in Peer Reviewed Research Publications
  1. Johnson MP, Evans MI. Intrauterine growth retardation: Pathophysiology and possibilities for intrauterine treatment. [Review] Fetal Therapy 2(2):109-122, 1987.
  2. Drugan A, Johnson MP, Evans MI. Infections following prenatal genetic procedures. [Review] Clinical Advances in the Treatment of Infections 2(6):14-16, Dec. 1988.
  3. Johnson MP, Drugan A, Miller OJ, Evans MI: Genetic correction of hereditary disease. [Review] Fetal Therapy 4 (Suppl 1):28-39, 1989.
  4. Jones T, Johnson MP, Drugan A, Evans MI. Preconceptual counseling. [Review] Obstetrics & Gynecology Clinics of North America 17(4):801-815, Dec. 1990.
  5. Drugan A, Dvorin E, O'Brien JE, Johnson MP, Evans MI. Alpha-fetoprotein. [Review] Current Opinion in Obstetrics and Gynecology 3(2):230-234, Apr. 1991.
  6. Sawyer JR, Johnson MP, Miller OJ. Traditional and molecular cytogenetics. [Review] Journal of Reproductive Medicine 37(6):485-498, June 1992.
  7. Evans MI, Dommergues M, Johnson MP, Dumez Y. Multifetal pregnancy reduction: Current status. Medicine Foetale 10:23-26, 1992.
  8. Evans MI, Pryde PG, Reichler A, Bardicef M, Johnson MP. Fetal drug therapy. [Review] Western Journal of Medicine 159(3):325-332, Sept. 1993.
  9. Pryde PG, Drugan A, Johnson MP, Isada NB, Evans MI. Prenatal diagnosis: choices women make about pursuing testing and acting on abnormal results. [Review] Clinical Obstetrics & Gynecology 36(3):496-509, Sept. 1993.
  10. Supulveda W, Berry SM, Romero R, King ME, Johnson MP, Cotton DB. Prenatal diagnosis of congenital megalourethra. [Review] Journal of Ultrasound in Medicine 12(12):761-766, Dec. 1993.
  11. Landwehr JB Jr., Isada NB, Pryde PG, Johnson MP, Evans MI, Canady AI. Maternal neurosurgi-cal shunts and pregnancy outcome. [Review] Obstetrics & Gynecology 83(1):134-37, Jan. 1994.
  12. Isada NB, Johnson MP, Pryde PG, Hallak M, Evans MI. Technical aspects of transcervical chorionic villus sampling. [Review] Fetal Diagnosis & Therapy 9(1):19-28, Jan./Feb. 1994.
  13. Evans MI, Adzick NS, Johnson MP, Flake AW, Quintero R, Harrison MR. [Review] Fetal therapy 1994. Current Opinion in Obstetrics & Gynecology 6(1):58-64, Feb. 1994.
  14. Hallak M, Pryde PG, Qureshi F, Johnson MP, Jacques SM, Evans MI. Constriction of the umbilical cord: Fetal death following transplacental amniocentesis. [Review] Journal of Reproductive Medicine 39(7):561-565, July 1994.
  15. Evans MI, O'Brien JE, Dvorin E, Johnson MP. Biochemical screening. [Review] Current Opinion in Obstetrics & Gynecology 6(5): 453-458, Oct. 1994.
  16. Pryde PG, Bardicef M, Klein M, Treadwell MC, Johnson MP, Isada NB, Crosslin K, Evans MI. Gastroschisis: Can ultrasound predict infant outcomes, and should it be used to alter obstetrical management? [Review] Obstetrics & Gynecology 84(4):505-510, Oct. 1994.
  17. Evans MI, Johnson MP. Genetic counseling, screening & diagnosis, and fetal therapy. [Review] Orgyn Bugamor International, The Netherlands, 2:21-25, 1994.
  18. Evans MI, Dommergues M, Johnson MP, Dumez Y. Multifetal pregnancy reduction and selective termination. [Review] Current Opinion in Obstetrics & Gynecology 7(2):126-129, Apr. 1995.
  19. Evans MI, Hume RH, Johnson MP. Controversies in early prenatal diagnosis. Medicine Foetale 20: 25-27, 1995.
  20. Evans MI, Johnson MP, Quintero RA, Fletcher JC. Ethical issues surrounding multifetal pregnancy reduction and selective termination. [Review] Clinics in Perinatology 23(3):437-451, Sept. 1996.
  21. Johnson MP, Evans MI. Advances in prenatal evaluation and patient selection. [Review] Dialogues in Pediatric Urology 19(4):2-3, 1996.
  22. Johnson MP, Flake AW. Modifications in technique based on hard lessons learned. [Review] Dialogues in Pediatric Urology 19(4):5-6, 1996.
  23. Evans MI, Johnson MP. Fetal reduction. Contemporary Obstetrics & Gynecology 41(6):27-28, 1996.
  24. Yaron Y, Ebrahim S, Kramer RL, Johnson MP, Evans MI. Fluorescent In Situ Hybridization (FISH) in prenatal diagnosis Fetal and Maternal Medicine Review 8:125-131, 1996.
  25. Yaron Y, Kramer RL, Johnson MP, Evans MI. Gene therapy: Is the future here yet? [Review] Obstetrics & Gynecology Clinics of North America 24(1):179-199, Mar. 1997.
  26. Stewart K, Johnson MP, Quintero RA, Evans MI. Congenital abnormalities in twins: Selective termination. [Review] Current Opinion in Obstetrics and Gynecology 9(2):136-139, Apr. 1997.
  27. Freedman AL, Bukowski TP, Smith CA, Evans MI, Berry SM, Gonzalez R, Johnson MP. The use of urinary B2 microglobulin to predict renal dysplasia in fetal obstructive uropathy. [Review] Fetal Diagnosis & Therapy 12(1):1-6, Jan./Feb. 1997.
  28. Evans MI, Kramer RL, Yaron Y, Drugan A, Johnson MP. What are the ethical and technical problems associated with multifetal pregnancy reduction? [Review] Clinical Obstetrics & Gynecology 41(1):47-54, Mar. 1998.
  29. Evans MI, Hume RF Jr., Yaron Y, Kramer RL, Johnson MP. Multifetal pregnancy reduction. [Review] Baillieres Clinical Obstetrics & Gynaecology 12(1):147-159, Mar. 1998.
  30. Brooks K, Chik L, O'Brien JE, Ayoub M, Johnson MP, Evans MI. Variability of adjustments to indices in determining patient risk in biochemical screening. [Review] Fetal Diagnosis & Therapy.14(1):41-46, Jan./Feb. 1999.
  31. Johnson MP, Freedman AL. Fetal uropathy. [Review] Current Opinion in Obstetrics & Gynecology 11(2):185-94, Apr. 1999.
  32. Kitano Y, Flake AW, Crombleholme TM, Johnson MP, Adzick NS. Open fetal surgery for life-threatening fetal malformations. [Review] Seminars in Perinatology 23(6):448-461, Dec. 1999.
  33. Walsh DS, Johnson MP. Fetal interventions for obstructive uropathy. [Review] Seminars in Perinatology 23(6):484-495, Dec. 1999.
  34. Drugan A, Johnson MP, Evans MI. Ultrasound screening for fetal chromosome anomalies. [Review] American Journal of Medical Genetics 90(2):98-107, Jan. 17, 2000.
  35. Freedman AL, Johnson MP, Gonzalez R. Fetal therapy for obstructive uropathy: Past, present, future? [Review] Pediatric Nephrology 14(2):167-76, Feb. 2000.
  36. Walsh DS, Adzick NS, Sutton LN, Johnson MP. The rationale for in utero repair of myelomeningocele. [Review] Fetal Diagnosis & Therapy 16(5):312-322, Sept./Oct. 2001.
  37. Evans MI, Harrison MR, Flake AW, Johnson MP. Fetal therapy. [Review] Best Practice & Research in Clinical Obstetrics & Gynaecology 16(5):671-683, Oct. 2002.
  38. Coleman BG, Adzick NS, Crombleholme TM, Johnson MP, Howell L, Horii SC, Langer JE, Nisenbaum HL, DeBari S, Iyoob C. Fetal therapy: State of the art. [Review] Journal of Ultrasound in Medicine 21(11):1257-1288, Nov. 2002.
  39. Evans MI, Johnson MP. The Wayne State experience. [Review] Fetal Diagnosis & Therapy 17(6):321-330, Nov./Dec. 2002.
  40. Crombleholme TM, Johnson MP. Fetoscopic surgery. [Review] Clinical Obstetrics & Gynecology 46(1):76-91, Mar. 2003.
  41. Hedrick HL, Flake AW, Crombleholme TM, Howell LJ, Johnson MP, Wilson RD, Adzick NS. History of fetal diagnosis and therapy: Children's Hospital of Philadelphia experience. [Review] Fetal Diagnosis & Therapy 18(2):65-82, Mar./Apr. 2003.
  42. Wilson RD, Johnson MP. Prenatal ultrasound guided percutaneous shunts for obstructive uropathy and thoracic disease. [Review] Seminars in Pediatric Surgery 12(3):182-189, Aug. 2003.
  43. Biard JM, Wilson RD, Johnson MP, Hedrick HL, Flake AW, Crombleholme TM, Adzick NS. Prenatally diagnosed giant omphaloceles: Short and long-term outcomes. [Review] Prenatal Diagnosis 24(6):434-439, June 2004.
  44. Wilson RD, Johnson MP. Congenital abdominal wall defects: An update. [Review] Fetal Diagnosis & Treatment 19(5):385-398, Sept./Oct. 2004.
  45. Rychik J, Tian Z, Cohen MS, Ewing SG, Cohen D, Howell LJ, Wilson RD, Johnson MP, Hedrick HL, Flake AW, Crombleholme TM, Adzick NS. Acute cardiovascular effects of fetal surgery in the human. [Review] Circulation 110(12):1549-1556, Sept. 21, 2004.
  46. Wilson RD, Hedrick HL, Liechty KW, Flake AW, Johnson MP, Bebbington MW, Adzick NS. Cystic adenomatoid malformation of the lung: Review of genetics, prenatal diagnosis and in utero treatment. [Review] American Journal of Medical Genetics 140(2A):151-155, Jan. 15, 2006.
  47. Wilson RD, Pawel B, Bebbington M, Johnson MP, Lim FY, Stamilio D, Silber A, Zakii E, Flake AW. Congenital pulmonary lymphangiectasis sequence: A rare, heterogeneous, and lethal etiology for prenatal pleural effusion. [Review] Prenatal Diagnosis 26(11):1058-1061, Nov. 2006.
  48. Mann S, Wilson RD, Bebbington MW, Adzick NS, Johnson MP. Antenatal diagnosis and management of congenital cystic adenomatoid malformation. [Review] Seminars in Fetal & Neonatal Medicine 12(6):477-481, Dec. 2007.
  49. Ilagan JG, Wilson RD, Bebbington M, Johnson MP, Hedrick HL, Liechty KW, Adzick NS. Pregnancy outcomes following bipolar umbilical cord cauterization for selective termination in complicated monochorionic multiple gestations. [Review] Fetal Diagnosis & Therapy 23(2):153-158, 2008.
  50. Husler MR, Wilson RD, Hori S, Bebbington MW, Adzick NS, Johnson MP. When is fetoscopic release of amniotic bands indicated? Review of outcome of cases treated in utero and selection criteria for fetal surgery. [Review] Prenatal Diagnosis 29(5):457-463, May 2009.
  51. Wu S, Johnson MP. Fetal lower urinary tract obstruction. [Review] Clinics in Perinatology 36(2):377-390, x, June 2009.
  52. Johnson MP, Danzer E. Outcomes following in utero myelomeningocele closure: What have we learned? [Review] Medecine Foetale et Echographie en Gynecologie 2009 (in press).
Research Publications, Non-Peer Reviewed
  1. Drugan A, O'Brien JE, Johnson MP, Isada NB, Evans MI. Alpha-fetoprotein and biochemical screening. Female Patient 16(12):37-44, 1991.
  2. Evans MI, Isada NB, Krivchenia EL, Uhlmann WR, Johnson MP. Management of the unexpectedly detected fetal abnormality. The Female Patient 18(10):72-77, 1993.
  3. Quintero RA, Johnson MP, Munoz H. In utero endoscopic treatment of posterior urethral valves: Preliminary experience. Prenatal Neonatal Medicine 3:208-216, 1998.
Abstracts
  1. Hedrick H, Danzer E, Zhao H, Aziz M, Flake A, Liechty K, Howell L, Johnson M, Wilson RD, Bebbington M, Adzick NS. Liver position is best prenatal predictor of need for ECMO and survival in left congenital diaphragmatic hernia. Society for Maternal-Fetal Medicine, 27th Annual Meeting, San Francisco, CA, Feb. 7-10, 2007.
  2. Rychik J, Donaghue D, Cohen M, Ewing S, Parry S, Johnson M, Wilson RD, Bebbington M, Gruber P, Gaynor JW, Spray T. Current outcomes for the fetus with hypoplastic left heart syndrome (HLHS). Society for Maternal-Fetal Medicine, 27th Annual Meeting, San Francisco, CA, Feb. 7-10, 2007.
  3. Johnson M, Wilson RD, Bebbington M, Gruber P, Gaynor JW, Spray T. NIH sponsored prospective randomized clinical trial of amnioreduction versus selective fetoscopic laser photocoagulation for twin-twin transfusion syndrome. Society for Maternal-Fetal Medicine, 27th Annual Meeting, San Francisco, CA, Feb. 7-10, 2007.
  4. Wilson RD, Johnson MP, Bebbington MW, Mann SE, Hedrick HL, Flake AW, Rychik J, Adzick NS. Sacrococcygeal teratoma: Prenatal surveillance, growth and pregnancy outcome. American Institute of Ultrasound in Medicine Annual Meeting, New York, NY, Mar. 15-18, 2007.
  5. Bebbington MW, Tiblad E, Wilson RD, Mann SE, Johnson MP. Outcomes in a cohort of patients with stage 1 twin-to-twin transfusion syndrome (TTTS) evaluated at a single center. Annual Meeting of the International Society of Ultrasound in Obstetrics & Gynecology, Oct. 8-11, 2007, Florence, Italy.
  6. Bebbington MW, Rychik J, Tian ZY, McCann P, Wilson RD, Mann SE, Huesler-Charles M, Johnson MP. The CHOP cardiovascular score for twin-to-twin transfusion syndrome: Effect of treatment with laser ablation. Annual Meeting of the International Society of Ultrasound in Obstetrics & Gynecology, Oct. 8-11, 2007, Florence, Italy.
  7. Bebbington MW, Danzer E, Hedrick H, Flake A, Wilson RD, Johnson MP, Adzick NS. Serial measurement of Lung Head Ratio (LHR) does not predict survival in left-sided congenital diaphragmatic hernia (CDH). Annual Meeting of the International Society of Ultrasound in Obstetrics & Gynecology, Oct., 8-11, 2007, Florence, Italy.
  8. Ilagan J, Wilson RD, Bebbington M, Coleman B, Horii S, Bilaniuk L, Simon-Schwartz E, Johnson M, Adzick NS. Ultrafast fetal magnetic resonance imaging (UF-MRI) as an adjunctive tool following prenatal ultrasound findings of top normal or mild ventriculomegaly (VM). Society for Maternal-Fetal Medicine, 28th Annual Meeting, Jan. 28-Feb. 2, 2008, Dallas, TX.
  9. Bebbington M, Huesler-Charles M, Rychik J, Wilson RD, Mann S, Danzer E, Johnson MP. The CHOP cardiovascular score: Parameter analysis to differentiate between early twin to twin transfusion syndrome (TTTS) and intrauterine growth restriction (IUGR). Society for Maternal-Fetal Medicine, 28th Annual Meeting, Jan. 28-Feb. 2, 2008, Dallas, TX.
  10. Mann S, Johnson MP, Rosner M, Wilson RD, Bebbington M. Prognostic indicators in twin reversed arterial perfusion sequence: Does size matter? Society for Maternal-Fetal Medicine, 28th Annual Meeting, Jan. 28-Feb. 2, 2008, Dallas, TX.
  11. Danzer E, Ernst LM, Johnson MP, Adzick S, Flake AW. In utero meconium passage in fetuses and newborns with myelomeningocele. Society for Maternal-Fetal Medicine, 28th Annual Meeting, Jan. 28-Feb. 2, 2008, Dallas, TX.
  12. Danzer E, Finkel RS, Rintoul N, Bebbington M, Simon-Schwartz E, Zarnow DM, Adzick S, Johnson MP. Reversal of hindbrain herniation after maternal-fetal surgery for myelomeningocele subsequently improves brain stem function. Society for Maternal-Fetal Medicine, 28th Annual Meeting, Jan. 28-Feb. 2, 2008, Dallas, TX.
  13. Danzer E, Rintoul NE, Gerdes M, Finkel R, Simon Schwartz EM, Adzick NS, Johnson MP. The relationship of seizures in early infancy and neurodevelopmental outcome following fetal myelo-meningocele closure. Pediatric Academic Society Annual Meeting, May 3-6, 2008, Honolulu, HI.
  14. Danzer E, Adzick NS, Rintoul NE, Zarnow DM, Simon Schwartz EM, Melchionni J, Sutton LN, Flake AW, Johnson MP. Dermoid cysts following fetal myelomeningocele closure: clinical implica-tion and follow-up. Pediatric Academic Society Annual Meeting, May 3-6, 2008, Honolulu, HI.
  15. Bebbington MW, Rychik J, Tian ZY, McCann P, Wilson RD, Mann SE, Johnson MP. Clinical validation of the CHOP cardiovascular score for twin-to-twin transfusion syndrome (TTTS). 18th World Congress on Ultrasound in Obstetrics and Gynecology, Aug. 24-28, 2008, Chicago, IL.
  16. Bebbington MW, Danzer E, Wright JH, Wilson RD, Mann SE, Johnson MP. A longitudinal study of the intrauterine growth of echogenic fetal lung masses. 18th World Congress on Ultrasound in Obstetrics and Gynecology, Aug. 24-28, 2008, Chicago, IL.
  17. Mann SE, Johnson MP, Ernst L, Rowling S, Wilson RD. Co-occurrence of multiple placental surface cysts and massive perivillous fibrin deposition in a fetus with left CDH: A case report. 18th World Congress on Ultrasound in Obstetrics and Gynecology, Aug. 24-28, 2008, Chicago, IL.
  18. Mann SE, Johnson MP, Sichko VM, Wilson RD, Bebbington MW. Fetoscopic surgery in triplet pregnancies with TRAP sequence. 18th World Congress on Ultrasound in Obstetrics and Gynecology, Aug. 24-28, 2008, Chicago, IL.
  19. Danzer E, Finkel RS, Rintoul N, Bebbington M, Sutton LN, Adzick S, Johnson MP. Fetal myelomeningocele closure reduces the severity and incidence of brainstem dysfunction. International Fetal Medicine and Surgery Society, 27th Annual Meeting, Sept. 12-16, 2008, Athens, Greece.
  20. Danzer E, Gerdes M, Zarnow D, Bebbington M, Adzick NS, Johnson MP. Preschool neurodevelopmental outcomes in children following fetal myelomeningocele closure. Society of Maternal Fetal Medicine 29th Annual Meeting, January 29-31, 2009, San Diego, CA.
  21. Bebbington MW, Rosner M, Wilson RD, Mann SE, Johnson MP. Perinatal outcomes with fetal chest shunts. Society of Maternal Fetal Medicine 29th Annual Meeting, January 29-31, 2009, San Diego, CA.
  22. Bebbington MW, Danzer E, Victoria T, Wilson RD, Johnson MP, Mann SE, Adzick NS, Hedrick H. MRI measurement of lung volume O/E ratio does not predict survival in left-sided congenital diaphragmatic hernia (CDH). Society of Maternal Fetal Medicine 29th Annual Meeting, January 29-31, 2009, San Diego, CA.
  23. Bebbington MW, Rychik J, Tian ZY, Zhao S, Johnson MP. Cardiovascular changes in the donor twin after laser therapy for twin-to-twin transfusion syndrome (TTTS). World Congress on Ultrasound in Obstetrics and Gynecology, 19th Annual Meeting, September 2009, Hamburg, Germany.
  24. Bebbington MW, Rychik J, Tian ZY, Zhao S, Johnson MP. The CHOP cardiovascular score for TTTS: Analysis of post laser effects. World Congress on Ultrasound in Obstetrics and Gynecology, 19th Annual Meeting, September 2009, Hamburg, Germany.
  25. Victoria T, Bebbington MW, Wilson RD, Epelman MS, Johnson MP, Jaramillo D. Can the selected use of low dose fetal CT aid in the prenatal diagnosis of skeletal dysplasias? World Congress on Ultrasound in Obstetrics and Gynecology, 19th Annual Meeting, September 2009, Hamburg, Germany.
  26. Danzer E, Gerdes M, Zarnow D, Bebbington M, Adzick NS, Johnson MP. Preschool neurodevelopmental outcomes in children following fetal myelomeningocele closure. International Fetal Medicine & Surgery Society, 28th Annual Meeting, September 6-8, 2009, Amazonia, Brazil.
  27. Moldenhauer JS, Kasperski SB, Huff DS, Victoria T, Johnson MP. Use of low dose fetal computed tomography (CT) for the prenatal diagnosis of achondrogenesis: A case report. Americal College of Medical Genetics, 17th Annual Meeting, March 24-28, 2010, Albuquerque, NM.
  28. Moldenhauer JS, Enod M, Bebbington MW, Adzick NS, Flake AW, Hedrick HL, Johnson MP. Maternal morbidity associated with the Ex-Utero Intrapartum Treatment (EXIT) procedure. Society of Maternal Fetal Medicine, 30th Annual Meeting, February 1-6, 2010, Chicago, IL.
  29. Danzer E, Gerdes M, Bebbington M, Koh J, Adzick NS, Johnson M. Preschool neurobehavioral outcome following fetal myelomeningocele surgery. Society of Maternal Fetal Medicine, 31st Annual Meeting, February 7-12, 2011, San Francisco, CA.
  30. (#400) Danzer E, Gerdes M, Bebbington M, Koh J, Adzick NS, Johnson M. Fetal myelomeningocele surgery: correlation of risk factors and preschool functional status using the Functional Independence Measure for Children (WeeFIM). Society of Maternal Fetal Medicine, 31st Annual Meeting, February 7-12, 2011, San Francisco, CA.
  31. Moldenhauer J, Johnson M, Endo M, Khalek N, Bebbinton M. Maternal obesity and outcomes with laser therapy for twin twin transfusion syndrome. Society of Maternal Fetal Medicine, 31st Annual Meeting, February 7-12, 2011, San Francisco, CA.
  32. Danzer E, Siegle J, D’Agostino JA, Gerdes M, Hoffman G, Bernbaum J, Rintoul NE, Flake AW, Adzick NS, Hedrick HL. Early neurodevelopmental outcome of infants with high-risk fetal lung lesions. International Fetal Medicine & Surgery Society, 30th Annual Meeting, May 13-18, 2011, Sedona, AZ.
  33. Moldenhauer JS, Endo M, Bebbington MW, Adzick NS, Flake AW, Hedrick HL, Johnson MP. Maternal morbidity associated with the ex-utero intrapartum treatment (EXIT) procedure. International Fetal Medicine & Surgery Society, 30th Annual Meeting, May 13-18, 2011, Sedona, AZ.
  34. Danzer E, Gerdes M, Bebbington MW, Koh J, Adzick NS, Johnson MP. Fetal myelomeningocele surgery: Preschool functional status using the Functional Independence Measure for Children (WeeFIM). International Fetal Medicine & Surgery Society, 30th Annual Meeting, May 13-18, 2011, Sedona, AZ.
  35. Johnson MP, Bebbington MW, Moldenhaur J, Khalek N, Howell L, Flake AW, Hedrick H, Adzick NS. Radiofrequency ablation (RFA) versus bipolar cord coagulation (BCC) in the management of complicated monochorionic twin pregnancies. International Fetal Medicine & Surgery Society, 30th Annual Meeting, May 13-18, 2011, Sedona, AZ.
  36. Bebbington MW, Johnson MP, Moldenhauer J, Khalek N, Rychik J, Tian ZY, Adzick NS. Right ventricular outflow tract obstruction (RVOTO) in monochorionic diamniotic twin gestations with TTTS. International Fetal Medicine & Surgery Society, 30th Annual Meeting, May 13-18, 2011, Sedona, AZ.
  37. Johnson MP. Risk factors for preterm delivery and uterine dehiscence following prenatal surgery for myelomeningocele. Society of Maternal Fetal Medicine, 32st Annual Meeting, February 6-11, 2012, Dallas, TX.
  38. Khalek N, Johnson MP. Natural history for pregnancies complicated by obstructive uropathy and normal amniotic fluid volume. Society of Maternal Fetal Medicine, 31st Annual Meeting, February 7-12, 2011, San Francisco, CA.
  39. Bebbington MW, Victoria T, Danzer E, Moldenhauer J, Khalek N, Johnson MP, Hedrick H, Adzick NS. The qualitative lung index (QLI): A useful new parameter or just more mathematics? World Congress on Ultrasound in Obstetrics and Gynecology, 22nd Annual Meeting, September 2012, Copenhagen, Denmark.
  40. Bebbington MW, Victoria T, Danzer E, Moldenhauer J, Khalek N, Johnson MP, Hedrick H, Adzick NS.Comarison of ultrasound and MRI parameters in predicting survival in isolated left-sided congenital diaphragmatic hernia (CDH): what works best? World Congress on Ultrasound in Obstetrics and Gynecology, 22nd Annual Meeting, September 2012, Copenhagen, Denmark.
  41. Bebbington MW, Moldenhauer J, Khalek N, Johnson MP. Estimated fetal weight (EFW) discordance in twin-to-twin transfusion syndrome: what does it mean? World Congress on Ultrasound in Obstetrics and Gynecology, 22nd Annual Meeting, September 2012, Copenhagen, Denmark.
  42. Vrecenak JD, Howell LJ, Khalek N, Moldenhauer JS, Johnson MP, Flake AW, Hedrick HL, Adzick NS. Outcomes of prenatally diagnosed chest masses in multiple gestations. American Pediatric Surgical Association, 44th Annual Meeting, May 2-5, 2013, Marco Island, FL.
  43. Danzer E, Thomas N, Sullivan A, Friedman K, Gerdes M, Hammond R, Koh J, Adzick NS, Johnson MP. Long-term neurological outcome, executive functioning, and behavioral adaptive skills following fetal myelomeningocele surgery. Society for Maternal-Fetal Medicine 33rd Annual Meeting, February 11-16, 2013, San Francisco, CA.
  44. Vrecenak JD, Bhatti T, Peranteau WH, Johnson MP, Flake AW. Donor specific tolerance of renal allografts following haploidentical in utero hematopoietic cell transplantation in the canine model. American College of Surgeions’ 99th Clinical Congress, October 6-10, 2013, Washington D.C.
Editorials, Chapters and Participation in Committee Reports
  1. Drugan A, Johnson MP, Evans MI. Genetics/Interactions. American College of Obstetrics and Gynecology. Volume II, 1989.
  2. Drugan A, Johnson MP, Evans MI. Genetic counseling. Clinical Consultation in Obstetrics and Gynecology. Philadelphia: WB Saunders, 1990.
  3. Drugan A, Johnson MP, Evans MI. Amniocentesis. In Eden RD, Boehm F (eds.). Fetal Assessment: Physiological, Clinical, and Medicolegal Principles. Norwalk, CT: Appleton & Lange, 1990, 283-290.
  4. Evans MI, Littmann L, King M, Johnson MP. Multifetal gestations: The role of selective termination. Clinics in Perinatology 19:345-357, 1992.
  5. Drugan A, Johnson MP, Evans MI. Principles of inheritance. In Evans MI (ed.): Reproductive Risks and Prenatal Diagnosis. Norwalk, CT: Appleton & Lange, 1992, 3-24.
  6. Isada NB, Johnson MP, Evans MI: Fetal infections. In Evans MI (ed.): Reproductive Risks and Prenatal Diagnosis. Norwalk, CT: Appleton & Lange, 1992, 111-120.
  7. Evans MI, Johnson MP. Chorionic villus sampling. In Evans MI (ed.): Reproductive Risks and Prenatal Diagnosis. Norwalk, CT: Appleton & Lange, 1992, 175-184.
  8. Johnson MP, Evans MI: Amniocentesis. In Evans MI (ed.): Reproductive Risks and Prenatal Diagnosis. Norwalk, CT: Appleton & Lange, 1992, 191-200.
  9. Johnson MP, Miller OJ: Cytogenetics. In Evans MI (ed.): Reproductive Risks and Prenatal Diagnosis. Norwalk, CT: Appleton & Lange, 1992, 237-250.
  10. Evans MI, Pinsky WP, Johnson MP, Schulman JD. Pharmacologic and gene therapy. In Evans MI (ed.): Reproductive Risks and Prenatal Diagnosis. Norwalk, CT: Appleton & Lange, 1992, 321-330.
  11. Evans MI, Johnson MP. Fetal metabolic and gene therapy. In Reece EA, Hobins JC, Mahoney MS, Petrie R (eds.): Medicine of the Fetus and its Mother. Philadelphia: Lippincott Harper, 1992, 815-830.
  12. Evans MI, Johnson MP, Isada NB, Holzgreve W. Selective termination. In Brock DJH, Rodeck CH, Ferguson-Smith MA (eds.): Prenatal Diagnosis and Screening. Philadelphia: WB Saunders, 1992, 118-141.
  13. Evans MI, Harrison MR, Johnson MP, Holzgreve W. Fetal medicine and surgery. In Fitzsimmons J, Stenchever MA (eds): Current Topics in Obstetrics and Gynecology: Prenatal Diagnosis. New York: Elsevier, 1993, 229-246.
  14. Kaufmann RA, Johnson MP, Evans MI. Genetics of the menopause. In Hajj SN, Mercer L, Evans WJ. Post Reproductive Gynecology. Norwalk, CT: Appleton & Lange, 1993, 36-41.
  15. Evans MI, Harrison M, Nicolaides KH, Johnson MP, Holzgreve W. Fetal therapy. In Milunsky A (ed): Genetic Disorders and the Fetus: Diagnosis, Prevention, and Treatment, 3rd Edition. Baltimore: Johns Hopkins Press, 1993, 771-797.
  16. Evans MI, Pryde PG, Johnson MP, Holzgreve W, Fletcher JC. Management of multifetal pregnancies discordant for fetal anomalies. In Simpson JL, Elias S (eds): Essentials of Prenatal Diagnosis. London: Churchill Livingstone, 1993, 331-345.
  17. Evans MI, Johnson MP. The genetics revolution and the role of the obstetrician. In Pitkin RM, Scott JB (eds): Clinical Obstetrics & Gynecology: The New Reproductive Genetics: Implications for Women and Their Physicians. Philadelphia: JB Lippincott, 1993, 36:463-465.
  18. Pryde PG, Drugan A, Johnson MP, Isada NB, Evans MI. Prenatal diagnosis: Choices women make about pursuing testing and acting on abnormal results. In Pitkin RM, Scott JB (eds): Clinical Obstetrics & Gynecology: The New Reproductive Genetics: Implications for Women and Their Physicians. Philadelphia: JB Lippincott, 1993, 36:496-509.
  19. Evans MI, Johnson MP, Drugan A. Amniocentesis for antenatal diagnosis of genetic disorders. In Quilligan EJ, Zuspan FP (eds): Current Therapy in Obstetrics and Gynecology, 4th Edition. Philadelphia: WB Saunders, 1994, 199-205.
  20. Isada NB, Johnson MP, Pryde PG, Evans MI. Prenatal diagnosis in the molecular age. In Avery GB, Fletcher MA (eds): Neonatology: Pathophysiology and Management of the Newborn, 4th Edition. Philadelphia: JB Lippincott, 1994, 97-108.
  21. Drugan A, Isada NB, Johnson MP, Hallak M, Evans MI. Prenatal diagnosis: Procedures and trends. In Avery GB, Fletcher MA (eds): Neonatology: Pathophysiology and Management of the Newborn, 4th Edition. Philadelphia: JB Lippincott, 1994, 144-153.
  22. Evans MI, Harrison MR, Johnson MP, Holzgreve W. Fetal therapy. In Avery GB, Fletcher MA (eds): Neonatology: Pathophysiology and Management of the Newborn, 4th Edition. Philadelphia: JB Lippincott, 1994, 171-183.
  23. Evans MI, Johnson MP, Isada NB, Holzgreve W. Coercion for fetal therapy? In Beller F, Werk R (eds): The Beginning of Human Life. Dordrecht, The Netherlands: Kluwer Academic Publishers, 1994, 319-324.
  24. Evans MI, Johnson MP, Hoffman EP, Holzgreve W. Fetal tissue biopsies. In James KD, Steer PJ, Weiner CP, Gonik B (eds.): High Risk Pregnancy: Management Options. Philadelphia: WB Saunders, 1994, 1015-1022.
  25. Evans MI, Littmann L, Isada NB, Johnson MP. Multifetal pregnancy reduction and selective termination. I In James KD, Steer PJ, Weiner CP, Gonik B (eds.): High Risk Pregnancy: Management Options. Philadelphia: WB Saunders, 1994, 1023-1029.
  26. Evans MI, Harrison MR, Adzick NS, Reichler A, Johnson MP. Fetal surgical and medical interventions. In Rock J, Gant N (eds.): Advances in Obstetrics & Gynecology. St. Louis: Mosby, 1994, 1:401-422.
  27. Johnson MP, Harrison MR, Adzick NS, Reichler A, Evans MI. Fetal gene therapy. In Rock J, Gant N (eds.): Advances in Obstetrics & Gynecology. St. Louis: Mosby, 1994, 1:423-435.
  28. Evans MI, Holzgreve W, Johnson MP, Ganshirt-Ahlert D, Sokol RJ. Fetal cell testing: Societal and ethical speculations. In Simpson JL, Elias S (eds): Fetal Cells in Maternal Blood. New York: NY Academy of Sciences, 1994, 731:257-261.
  29. Evans MI, Hallak M, Johnson MP. Prenatal diagnosis. In Reich WT (ed.): Encyclopedia of Bioethics, Volume II. New York: MacMillan, 1995, 986-991.
  30. Evans MI, Reichler A, Isada NB, Pryde PG, Johnson MP. Treatment of fetal metabolic and hormonal defects. In Spitzer AR (ed.): Intensive Care of the Fetus and Neonate. Philadelphia: JB Lippincott, 1995, 157-163.
  31. Isada NB, Drugan A, Johnson MP, Evans MI. Adult genetic disease. Chap. 1 in Isada NB, Johnson MP, Drugan A, Evans MI (eds): Maternal Genetic Disease. Norwalk, CT: Appleton & Lange, 1995, 1-3.
  32. Evans MI, Drugan A, Pryde P, Johnson MP. Genetics and the obstetrician. Chap. 2 in Isada NB, Johnson MP, Drugan A, Evans MI (eds): Maternal Genetic Disease. Norwalk, CT: Appleton & Lange, 1995, 5-6.
  33. Jones T, Drugan A, Johnson MP, Evans MI. Genetics: An overview. Chap. 3 in Isada NB, Johnson MP, Drugan A, Evans MI (eds): Maternal Genetic Disease. Norwalk, CT: Appleton & Lange, 1995, 7-26.
  34. Jones T, Drugan A, Johnson MP, Evans MI. Preconceptional counseling. Chap. 4 in Isada NB, Johnson MP, Drugan A, Evans MI (eds): Maternal Genetic Disease. Norwalk, CT: Appleton & Lange, 1995, 27-31.
  35. Isada NB, Johnson MP, Evans MI. Maternal inborn errors of metabolism. Chap. 13 in Isada NB, Johnson MP, Drugan A, Evans MI (eds): Maternal Genetic Disease. Norwalk, CT: Appleton & Lange, 1995, 125-160.
  36. Johnson MD, Johnson MP, Drugan A. Maternal endocrine diseases. Chap. 15 in Isada NB, Johnson MP, Drugan A, Evans MI (eds): Maternal Genetic Disease. Norwalk, CT: Appleton & Lange, 1995, 181-202.
  37. Evans MI, Johnson MP. Fetal reduction. In Queenan JT, Hobbins JC (eds): Protocols in High Risk Pregnancies. Cambridge, MA: Blackwell Science, 1995, 571-576.
  38. Drugan A, Johnson MP, Krivchenia EL, Evans MI. The genetics and genetic counseling of multiple gestation. In, Gall SA (ed.): Multiple Pregnancy and Delivery. St. Louis: Mosby, 1996, 85-97.
  39. Evans MI, Hume RF, Johnson MP. Genetic and prenatal diagnostic techniques. In Fisher CW (ed): Risk Management Techniques in Perinatal and Neonatal Medicine. Mt. Kisco, NY: Futura, 1996, 15-28.
  40. Hume RF, Martin LS, Johnson MP, Evans MI. Metabolic disorders. Chap. 5 in Fisk N, Moise K (eds): Fetal Therapy: Invasive and Transplacental. Cambridge, United Kingdom: Cambridge University Press, 1997, 50-59.
  41. Hume RF, Martin LS, Isada NB, Johnson MP, Evans MI. Perspectives of metabolic diseases in pregnancy: A trip through time. In Platt LD, De la Cruz F (eds): Effects of Genetic Disorders on Pregnancy Outcome. London: Parthenon Press, 1997, 1-19.
  42. Flake AW, Quintero RA, Johnson MP, Evans MI. Fetal intervention. In Szabo Z, Lewis JE, Fantim GA (eds): Surgical Technology International IV. San Francisco: Universal Medical Press, 1997, 171-176.
  43. Kramer RL, Yaron Y, Johnson MP, Evans MI. New genetic mechanisms. Chap. 16 in Gleisher N, Buttino L Jr., Elkayam U, Evans MI, Galbraith RM, Gall SA, Sibai BM (eds): Principles and Prac-tices of Medical Therapy in Pregnancy,3rd Edition. Norwalk, CT: Appleton & Lange, 1998, 155-159.
  44. Evans MI, Johnson MP. Prenatal diagnosis. Chap. 20 in Gleisher N, Buttino L Jr., Elkayam U, Evans MI, Galbraith RM, Gall SA, Sibai BM (eds): Principles and Practices of Medical Therapy in Pregnancy,3rd Edition. Norwalk, CT: Appleton & Lange, 1998, 178-191.
  45. Johnson MP, Flake AW, Harrison MR, Quintero R, Evans MI. In utero therapy of the fetus. Chap. 25 in Gleisher N, Buttino L Jr., Elkayam U, Evans MI, Galbraith RM, Gall SA, Sibai BM (eds): Principles and Practices of Medical Therapy in Pregnancy,3rd Edition. Norwalk, CT: Appleton & Lange, 1998, 223-235.
  46. Evans MI, Rodeck CH, Stewart KS, Quintero RA, Yaron Y, Johnson MP. Multiple gestation: Genetic issues, selective termination and fetal Reduction. Chap. 26 in Gleisher N, Buttino L Jr., Elkayam U, Evans MI, Galbraith RM, Gall SA, Sibai BM (eds): Principles and Practices of Medical Therapy in Pregnancy,3rd Edition. Norwalk, CT: Appleton & Lange, 1998, 235-241.
  47. Drugan A, Johnson MP, Evans MI. Disorders of metals and metalloproteins. Chap. 43 in Gleisher N, Buttino L Jr., Elkayam U, Evans MI, Galbraith RM, Gall SA, Sibai BM (eds): Principles and Practices of Medical Therapy in Pregnancy,3rd Edition. Norwalk, CT: Appleton & Lange, 1998, 370-376.
  48. Evans MI, Johnson MP, Quintero RA, Fletcher JC. Multifetal pregnancy reduction: Ethical issues. In Freed G, Hageman J (eds.): Clinics in Perinatology: Ethical Dilemmas in the Prenatal, Perinatal, and Neonatal Period. 22(3):189-197, 1998.
  49. Evans MI, Johnson MP. Multifetal pregnancy reduction. Chap. 26 in Reece EA, Hobbins J (eds.): Medicine of the Fetus and Mother, 2nd Edition. Philadelphia: Lippincott/Raven, 1998, 1433-1438.
  50. Evans MI, Flake AW, Harrison MR, Quintero RA, Johnson MP. Fetal therapy. In Milunsky A (ed.): Genetic Disorders and the Fetus: Diagnosis, Prevention, and Treatment, 4th Edition. Baltimore: Johns Hopkins Press, 1998, 952-971.
  51. Evans MI, Johnson MP, Hoffmann EP, Holzgreve W. Fetal tissue biopsies. Chap. 15 in James DK, Star PJ, Weiner CP, Gonik B (eds): High Risk Pregnancy: Management Options. Philadelphia: WB Saunders, 1999, 235-242.
  52. Evans MI, Johnson MP. Multifetal pregnancy reduction and selective termination. Chap. 16 in James DK, Star PJ, Weiner CP, Gonik B (eds.): High Risk Pregnancy: Management Options. Philadelphia: WB Saunders, 1999, 243-248.
  53. Drugan A, Isada NB, Johnson MP, Hallak M, Evans MI. Prenatal diagnosis: Procedures & trends. Chap. 12 in Avery GB, MacDonald M, Fletcher MA (eds.): Neonatology: Pathophysiology and Management of the Newborn, 5th Edition. Philadelphia: Lippincott-Raven, 1999, 161-172, 1999.
  54. Evans MI, Harrison M, Johnson MP, Feldman B, Holzgreve W. Fetal therapy. Chap. 13 in, Avery GB, MacDonald M, Fletcher MA (eds.): Neonatology: Pathophysiology and Management of the Newborn, 5th Edition. Philadelphia: Lippincott-Raven, 1999, 173-187.
  55. Yaron Y, Flake AQ, Zanjani E, Johnson MP, Evans MI. Stem cell fetal therapy. Chap. 9 in Evans MI, Rodeck CH (eds.): Progress in Obstetrics and Gynecology – Sonography Series, Ultrasound and Fetal Therapy. London: Parthenon Publishing, 2000, 105-112.
  56. Evans MI, Henry G, Miller W, Bui T, Snijders R, Wapner R, Miny P, Johnson M, Peakman D, Johnson A, Nicolaides K, Holzgreve W, Ebrahim S, Jackson L. Letter to the Editor Human Reproduction 15:229-230, 2000.
  57. Evans MI, Harrison MR, Flake AW, Johnson MP. Fetal therapeutic intervention. Chap. 11 in Gabbe SG, Niebyl JR, and Simpson JL (eds.): Obstetrics: Normal and Problem Pregnancies, 4th Edition. Philadelphia: Churchill Livingston, 2001, 297-312.
  58. Johnson MP. Fetal obstructive uropathy. Chap. 18 in Harrison MR, Evans MI, Adzick NS, Holzgreve W (eds.): The Unborn Patient: The Art and Science of Fetal Therapy. Philadelphia: WB Saunders, 2001, 259-286.
  59. Keswani SG, Wilson RD, Johnson MP. Percutaneous intrauterine fetal shunting. In Apuzzio JJ, Vintzileos AM, Iffy L (eds.): Operative Obstetrics, 3rd Edition. London: Taylor & Francis Books, 2006, 109-120.
  60. Treadwell M, Johnson MP. Genito-urinary tract abnormalities. Chap. 21 in Evans MI, Johnson MP (eds.): Prenatal Diagnosis: Genetics, Reproductive Risks, Testing, and Management. Norwalk, CT: Appleton & Lange Publishing Co., 2006, 257-262.
  61. Evans MI, Rodeck CH, Johnson MP, Berkowitz RL. Selective termination. Chap. 52 in Evans MI, Johnson MP (eds.): Prenatal Diagnosis: Genetics, Reproductive Risks, Testing, and Management. Norwalk, CT: Appleton & Lange Publishing Co., 2006, 571-578.
  62. Johnson MP. Fetal shunt procedures. Chap. 55 in Evans MI, Johnson MP (eds.): Prenatal Diagnosis: Genetics, Reproductive Risks, Testing, and Management. Norwalk, CT: Appleton & Lange Publishing Co., 2006, 605-616.
  63. Mann S, Johnson M. Fetal tumours. Chap. 38 in Rodeck, Whittle (eds.): Fetal Medicine, 2nd Edition. Edinburgh: Elsevier Ltd., 2008, 528-537.
  64. Sarno AP, MW Bebbington, RD Wilson, MP Johnson. Fetal Lower Urinary Tract Obstruction.  In, Gratacos E and Cabero Roura L (eds): Tatado de Medina Fetal. Editorial Medica Panamericana, Madrid, Spain, 2008.
  65. Bebbington MW, Johnson MP, Wilson RD, Adzick NS. Open Fetal Surgery. In, van Vugt JMG and Shulman LP (eds): Fetal Medicine, Marcel Dekker Publishers 2008.
Books
  1. Evans MI, Johnson MP (guest editors). Prenatal Genetics in the 90s. St. Louis: Mosby, 1992.
  2. Isada NA, Johnson MP, Drugan A, Evans MI (editors). Maternal Genetic Disease. Norwalk, CT: Appleton & Lange Publishing Co., 1996.
  3. Evans MI, Johnson MP, Moghissi KS (editors). Invasive Outpatient Procedures in Reproductive Medicine. New York: Raven Press, 1997.
  4. Evans MI, Johnson MP (editors). Prenatal Diagnosis: Genetics, Reproductive Risks, Testing, and Management. Norwalk, CT: Appleton & Lange Publishing Co., 2006.
 
Awards
2013 Philadelphia Super Doctors
 
2004. Alumni Achievement Award, Concordia College
 
2000 George Leib Harrison Endowed Chair in Fetal Therapy
The Children’ Hospital of Philadelphia
 
2014 Best Doctors in America
(1998-1999, 2003, 2008, 2009, 2010, 2011, 2012, 2013, 2014)
 
1998 Wayne State University College Teaching Award, Department of Ob/Gyn
 
1998 Wayne State University Alpha Omega Alpha Medical Honor Society
in recognition for outstanding achievement in medical student education
 
1996 & 1997 Wayne State University Faculty Teaching Award, Department of Ob/Gyn
 
1996 Best Doctors in Detroit, Detroit Monthly Magazine
 
1995 Best Doctors in Midwest America, Woodward/White, Inc. 
 
1995 Hole-in-One, Hutzel Hospital Annual Fund Raising Golf Outing
15th Hole, 165 yards, 6 iron, North Course, Detroit Country Club
 
1997 President, and Scientific Program Director for the 16th Annual Meeting of the International Fetal Medicine & Surgery Society
 
1993 Cited as one of the "New Generation of Community Leaders in Detroit" in anarticle entitled "Passing the Baton...the chosen 75 who represent the next generation" by the Detroit Monthly Magazine,
 
1991 Citation's "Who's Who Among Rising Young Americans",
 
1990 Third Place Award, Original Contributions to the Field of Fetal Medicine, "Evaluation of Midgestational Growth Patterns in Aneuploid Fetuses Using Exponential Power Equation Analysis, The Fetus as a Patient '90, The Sixth International Symposium, Detroit, Michigan
 
1990 First Place Award, Outstanding Research Paper by a Fellow-in-training,
"A Defect in Type I Collagen: RFLP Prenatal Diagnosis of Type II, Osteogenesis Imperfecta", Michigan Section American College of Obstetrics & Gynecology
Annual Research Paper Day, Oakwood Hospital, Dearborn, Michigan
 
1990 First Place Award, Outstanding Research Paper,
"Midtrimester Organ Specific Growth Retardation Varies in Differing
Aneuploid States: Use of Exponential Power Equation Analysis to Model
Normal and Abnormal Fetal Growth", Department of Obstetrics &
Gynecology, Wayne State University, Resident and Fellows Research Paper
Day, May 1, 1990, Hutzel Hospital/Wayne State University, Detroit, Michigan
 
1987 Galens' Medical Society "Bronze Beeper" Award, for "Outstanding effort and achievement in the teaching and training of medical students",
University of Michigan, Ann Arbor, Michigan
 
1982 - 1983 Rural Physicians Associate Program: chosen from medical school class to
participate in a special clinical program as a practicing physician's associate in a small
rural community as part of the third year medical school curiculum.
Assigned: Canby, MN., population 1900, for 9 months in 1982-83.

Dr. Mark Johnson

 
footer Terms of Use Legal Disclaimer Site Map Contact Us Financial Assistance About Penn Medicine Privacy Statement
penn medicine